Please sign in to follow a disease.
Autoimmune disease
MONDO:0007179A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to their own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).
Also known as: autoimmune disease, autoimmune disease or disorder, autoimmune disorder, disease, autoimmune, autoimmune hypersensitivity disease, hypersensitivity reaction type II disease
4049 clinical trials for this condition and its sub-types, 315 tagged with Autoimmune disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Autoimmune disease
-
Autoimmune disorder of the nervous system 47 trials · 1,067 incl. sub-types
4 sub-types
- Autoimmune disorder of central nervous system 2 trials · 881 incl. sub-types Sub-types →
- Autoimmune disorder of peripheral nervous system 0 trials · 195 incl. sub-types Sub-types →
- Pediatric acute-onset neuropsychiatric syndrome 8 trials · 10 incl. sub-types Sub-types →
- Autoimmune retinopathy 0 trials
-
Autoimmune disorder of gastrointestinal tract 0 trials · 942 incl. sub-types
7 sub-types
- Type 1 diabetes mellitus 819 trials · 820 incl. sub-types Sub-types →
- Celiac disease 81 trials Sub-types →
- Autoimmune hepatitis 30 trials · 31 incl. sub-types Sub-types →
- Autoimmune enteropathy 2 trials · 11 incl. sub-types Sub-types →
- Autoimmune gastritis 3 trials
- Autoimmune pancreatitis 3 trials Sub-types →
- IgG4-related sclerosing cholangitis 0 trials
-
Autoimmune disorder of endocrine system 1 trial · 929 incl. sub-types
13 sub-types
- Type 1 diabetes mellitus 819 trials · 820 incl. sub-types Sub-types →
- Autoimmune thyroid disease 8 trials · 62 incl. sub-types Sub-types →
- Autoimmune hepatitis 30 trials · 31 incl. sub-types Sub-types →
- Autoimmune polyendocrinopathy 3 trials · 11 incl. sub-types Sub-types →
- Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
- Autoimmune hypoparathyroidism 0 trials · 8 incl. sub-types Sub-types →
- Autoimmune pancreatitis 3 trials Sub-types →
- Autoimmune primary ovarian failure 1 trial
- IgG4-related sclerosing cholangitis 0 trials
- Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome 0 trials
- Autoimmune oophoritis 0 trials
- Insulin autoimmune syndrome 0 trials
- Primary hypophysitis 0 trials Sub-types →
-
CNS demyelinating autoimmune disease 5 trials · 859 incl. sub-types
1 sub-type
- Multiple sclerosis 770 trials · 858 incl. sub-types Sub-types →
-
Autoimmune disorder of musculoskeletal system 0 trials · 797 incl. sub-types
3 sub-types
- Rheumatoid arthritis 578 trials · 797 incl. sub-types Sub-types →
- Autoimmune cardiomyopathy 0 trials Sub-types →
- Neonatal dermatomyositis 0 trials
-
Lupus erythematosus 40 trials · 551 incl. sub-types
3 sub-types
- Systemic lupus erythematosus 518 trials · 524 incl. sub-types Sub-types →
- Cutaneous lupus erythematosus 38 trials · 46 incl. sub-types Sub-types →
- Drug-induced lupus erythematosus 1 trial
-
Scleroderma 47 trials · 305 incl. sub-types
3 sub-types
- Systemic sclerosis 261 trials · 295 incl. sub-types Sub-types →
- Localized scleroderma 14 trials · 15 incl. sub-types Sub-types →
- Neonatal scleroderma 0 trials
-
Autoimmune disorder of exocrine system 0 trials · 197 incl. sub-types
3 sub-types
- Sjogren syndrome 167 trials
- Autoimmune hepatitis 30 trials · 31 incl. sub-types Sub-types →
- Benign lymphoepithelial lesion of salivary gland 0 trials
-
Autoimmune disorder of blood 0 trials · 152 incl. sub-types
2 sub-types
- Primary thrombocytopenia 27 trials · 110 incl. sub-types Sub-types →
- Autoimmune hemolytic anemia 49 trials · 72 incl. sub-types Sub-types →
-
Autoimmune thrombocytopenia 8 trials · 113 incl. sub-types
2 sub-types
- Autoimmune thrombocytopenic purpura 95 trials
- Evans syndrome 19 trials
-
Vitiligo 100 trials
3 sub-types
- Generalized vitiligo 16 trials
- Alopecia universalis onychodystrophy vitiligo 0 trials
- Trichrome vitiligo 0 trials
-
Antiphospholipid syndrome 58 trials · 59 incl. sub-types
4 sub-types
- Primary antiphospholipid syndrome 4 trials
- Catastrophic antiphospholipid syndrome 1 trial
- Familial antiphospholipid syndrome 0 trials
- Secondary antiphospholipid syndrome 0 trials Sub-types →
-
Autoimmune bullous skin disease 7 trials · 56 incl. sub-types
11 sub-types
- Pemphigus 20 trials · 28 incl. sub-types Sub-types →
- Bullous pemphigoid 18 trials
- Mucous membrane pemphigoid 5 trials · 9 incl. sub-types Sub-types →
- Acquired epidermolysis bullosa 3 trials
- Dermatitis herpetiformis 1 trial Sub-types →
- Pemphigoid 1 trial
- IgA pemphigus 0 trials
- Anti-p200 pemphigoid 0 trials
- Linear IgA Dermatosis 0 trials
- Paraneoplastic pemphigus 0 trials
- Subcorneal pustular dermatosis 0 trials
-
Immunoglobulin G4-related sclerosing disease 30 trials · 34 incl. sub-types
14 sub-types
- Autoimmune pancreatitis 3 trials Sub-types →
- IgG4-related kidney disease 1 trial
- IgG4-related retroperitoneal fibrosis 1 trial Sub-types →
- IgG4-related aortitis 0 trials
- IgG4-related mediastinitis 0 trials
- IgG4-related mesenteritis 0 trials
- IgG4-related ophthalmic disorder 0 trials Sub-types →
- IgG4-related pachymeningitis 0 trials
- IgG4-related sclerosing cholangitis 0 trials
- IgG4-related submandibular gland disease 0 trials
- IgG4-related thyroid disease 0 trials
- Cutaneous pseudolymphoma 0 trials
- Eosinophilic angiocentric fibrosis 0 trials
- Primary cutaneous plasmacytosis 0 trials
-
Rheumatic fever 17 trials
-
Overlapping connective tissue disease 2 trials · 15 incl. sub-types
2 sub-types
- Mixed connective tissue disease 15 trials
- MASS syndrome 0 trials
-
Autoimmune lymphoproliferative syndrome 11 trials · 12 incl. sub-types
9 sub-types
- Autoimmune lymphoproliferative syndrome type 4 3 trials
- FAS-related autoimmune lymphoproliferative syndrome 2 trials
- Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 1 trial
- Castleman-Kojima disease 0 trials
- Autoimmune lymphoproliferative syndrome type 1 0 trials
- Autoimmune lymphoproliferative syndrome type 2A 0 trials
- Autoimmune lymphoproliferative syndrome type 2B 0 trials
- Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD 0 trials
- Type 3 autoimmune lymphoproliferative syndrome 0 trials
-
Type III hypersensitivity disease 3 trials · 6 incl. sub-types
2 sub-types
- Serum sickness 3 trials
- Arthus reaction 0 trials
-
Autoimmune disease of ear, nose and throat 0 trials · 4 incl. sub-types
7 sub-types
- Autoimmune inner ear disease 2 trials
- Autoimmune uveitis 2 trials
- Cogan syndrome 0 trials
- IgG4-related dacryoadenitis and sialadenitis 0 trials
- IgG4-related submandibular gland disease 0 trials
- Autoimmune retinopathy 0 trials
- Eosinophilic angiocentric fibrosis 0 trials
-
Cryoglobulinemia 3 trials
1 sub-type
- Cryofibrinogenemia 0 trials Sub-types →
-
Autoimmune disorder of cardiovascular system 0 trials · 3 incl. sub-types
6 sub-types
- Chilblain lupus 1 trial · 3 incl. sub-types Sub-types →
- Libman-Sacks endocarditis 0 trials
- Autoimmune atherosclerosis 0 trials
- Autoimmune cardiomyopathy 0 trials Sub-types →
- Autoimmune vasculitis 0 trials Sub-types →
- Rheumatic pulmonary valve disease 0 trials
-
Susac syndrome 2 trials
-
Autoimmune disease, multisystem, infantile-onset 0 trials · 2 incl. sub-types
-
Phacolytic glaucoma 1 trial
-
Secondary neonatal autoimmune disease 0 trials · 1 incl. sub-types
6 sub-types
- Neonatal lupus erythematosus 1 trial
- Neonatal antiphospholipid syndrome 0 trials
- Neonatal autoimmune hemolytic anemia 0 trials
- Neonatal dermatomyositis 0 trials
- Neonatal scleroderma 0 trials
- Transient neonatal myasthenia gravis 0 trials
-
Jaccoud syndrome 0 trials
-
Kimura disease 0 trials
-
Reynolds syndrome 0 trials
-
Autoimmune glomerulonephritis 0 trials
-
Autoimmune urticaria 0 trials
-
Euthyroid Graves orbitopathy 0 trials
-
Tempi syndrome 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 1112 trials in this tab.
-
HPV vaccine shows promise for girls on Immune-Suppressing drugs
Vaccine CompletedThis study looked at whether the HPV vaccine works in girls aged 9 to 17 who are taking medicines that weaken their immune system, such as after an organ transplant or for diseases like lupus. The goal was to see if their bodies produce enough antibodies to protect against HPV. T…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Vaccine
Last updated Jun 27, 2026 12:36 UTC
-
Can a JAK inhibitor boost remission in IgG4-Related disease?
Disease control CompletedResearchers are testing whether adding tofacitinib to prednisone works better than prednisone alone for people with active IgG4-related disease. The trial enrolls 58 adults with active disease and assigns them to either tofacitinib plus prednisone or prednisone alone. The main go…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Smart pen cap could help tame blood sugar in type 1 diabetes
Disease control CompletedThis study tested a smart cap that attaches to insulin pens to help people with type 1 diabetes track their injections and glucose data. 42 adults used the device or a blinded version for comparison. The goal was to see if it reduces time spent with high blood sugar and improves …
Sponsor: Fernando Sebastián Valles • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a glucose sensor and family coaching tame type 1 diabetes in toddlers?
Disease control CompletedResearchers are testing whether continuous glucose monitoring, alone or combined with a family behavioral program, helps children under 8 with type 1 diabetes keep their blood sugar in a healthy range. The trial compares these approaches to standard home blood glucose monitoring.…
Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could cord cell secretions ease arthritis pain?
Disease control CompletedThis study tests whether a substance produced by umbilical cord cells can help control moderate rheumatoid arthritis. Participants receive weekly injections of either the cell substance or a placebo for six weeks, alongside their usual medication. The goal is to see if it improve…
Phase 2 • Sponsor: Universitas Sriwijaya • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a pill shield celiac patients from accidental gluten?
Disease control CompletedThis study tested whether the drug ritlecitinib could prevent intestinal damage and symptoms when people with celiac disease ate gluten. 62 adults with well-controlled celiac disease (on a gluten-free diet) took either the drug or a placebo along with a daily gluten challenge. Th…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a math model tune insulin pumps better than standard care?
Disease control CompletedResearchers at Nantes University Hospital are testing a computer model that describes how glucose and insulin interact in people with type 1 diabetes. The model aims to help doctors choose insulin pump settings, including basal rate, insulin sensitivity, and carbohydrate ratios. …
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug shows promise for Sjögren's sufferers
Disease control CompletedThis Phase 3 trial tests dazodalibep, a drug given by IV, in 651 people with moderate-to-severe Sjögren's syndrome. The goal is to see if it reduces disease activity and improves symptoms like dryness and fatigue. Participants receive either the drug or a placebo, and researchers…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a new drug calm the immune System's attack on blood cells?
Disease control CompletedThis study is testing an experimental drug called povetacicept in adults with autoimmune cytopenias — conditions where the immune system mistakenly destroys blood cells, leading to low platelet counts (immune thrombocytopenia) or anemia (autoimmune hemolytic anemia and cold agglu…
Phase 1/2 • Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can an approved arthritis drug stop early joint damage?
Disease control CompletedResearchers are testing whether apremilast helps people with early psoriatic arthritis that affects only a few joints. Participants have had symptoms for five years or less and still have joint pain and swelling despite stable treatment with NSAIDs or one conventional DMARD. The …
Phase 4 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pump insulin could speed up blood sugar control for type 1 diabetes
Disease control CompletedThis completed Phase 1 study tested a new fast-acting insulin called NNC0471-0119 in 43 adults with type 1 diabetes who use an insulin pump. The goal was to see how quickly the insulin enters the bloodstream, how long it works, and how safe it is compared to a standard insulin (i…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of back pain condition
Disease control CompletedThis study is testing the long-term safety and effectiveness of bimekizumab, a drug that reduces inflammation, in 508 adults with active axial spondyloarthritis (including ankylosing spondylitis). Participants who completed earlier trials will receive the drug for an extended per…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Nanobody injection put to the test against psoriatic arthritis
Disease control CompletedResearchers are testing an experimental drug called sonelokimab in adults with active psoriatic arthritis, a condition that causes painful, swollen joints along with skin psoriasis. The trial compares sonelokimab injections with placebo injections, and also includes a third group…
Phase 2 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a common diabetes pill boost arthritis remission?
Disease control CompletedThis study tests whether adding metformin, a diabetes drug, to standard methotrexate therapy helps more people with rheumatoid arthritis achieve disease control. About 128 adults with active RA who have not recently taken methotrexate will receive either methotrexate plus metform…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a Low-Dose booster keep platelets up in ITP?
Disease control CompletedResearchers test whether giving low-dose rituximab after an initial treatment can make the response last longer in adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The trial enrolls adults whose ITP has not responded well to steroi…
Phase 3 • Sponsor: Ostfold Hospital Trust • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a faster insulin improve blood sugar control in teens with type 1 diabetes?
Disease control CompletedThis completed trial tested whether a faster-acting insulin (Lyumjev) used with a special conversion factor in an automated insulin pump (Control-IQ) could improve blood sugar control in 11 adolescents with type 1 diabetes. Participants were randomly assigned to use Lyumjev with …
Sponsor: Mark D. DeBoer, MD, MSc., MCR • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug shows promise for Long-Term psoriatic arthritis control
Disease control CompletedThis study looked at the long-term safety and effectiveness of bimekizumab in adults with active psoriatic arthritis. Over 1,100 people who completed earlier studies received the drug and were monitored for side effects and disease symptoms. The goal was to see if bimekizumab rem…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection calm rheumatoid arthritis? an early trial puts ZB002 to the test
Disease control CompletedThis early-stage trial evaluates an experimental drug called ZB002, given as an injection under the skin. In the first part, healthy volunteers receive a single dose to check safety and how the drug moves through the body. In the second part, people with rheumatoid arthritis rece…
Phase 1 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Hope for teens with down syndrome regression disorder: old drugs, new purpose
Disease control CompletedThis Phase 2 trial tests three commonly used drugs—lorazepam, IVIG, and tofacitinib—in 66 people aged 8 to 30 with Down Syndrome Regression Disorder (DSRD). DSRD causes sudden severe symptoms like loss of speech, movement, and daily living skills. The study aims to see if these d…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Head-to-Head: which drug works better for psoriatic arthritis?
Disease control CompletedThis study tests whether bimekizumab works better than risankizumab for adults with active psoriatic arthritis (PsA), a condition causing joint pain and skin lesions. About 684 participants will receive one of the two drugs for 16 weeks. The main goal is to see who gets at least …
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a gut bacteria booster ease rheumatoid arthritis?
Disease control CompletedThis pilot study tested whether a butyrate supplement, a type of short-chain fatty acid, could change the gut microbiome and immune responses in people with rheumatoid arthritis who didn't respond well to methotrexate. Twenty participants took the supplement for up to two months.…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new topical cream tame cutaneous lupus?
Disease control CompletedThis early-stage trial tests the safety and tolerability of SOF-SKN, a cream applied to the skin, in healthy volunteers aged 18 to 64. The study has two parts: one applies a single dose, and the other applies daily doses for two weeks, with escalating strengths. Researchers monit…
Early phase 1 • Sponsor: Noxopharm Limited • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for type 1 diabetes: can common diabetes drugs improve blood sugar control?
Disease control CompletedThis study tests whether adding empagliflozin or semaglutide to insulin can improve blood sugar control in overweight or obese adults with type 1 diabetes. About 105 participants will take one of the two drugs or a placebo for 3 months. The goal is to see if these drugs help lowe…
Phase 2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
RINVOQ tested in Real-World study for back pain disease
Disease control CompletedThis study tested the drug RINVOQ in 69 adults with ankylosing spondylitis, a type of arthritis that mainly affects the spine. Participants took RINVOQ as prescribed by their doctor and were followed for up to a year. The goal was to see how safe and effective the drug is in real…
Sponsor: AbbVie • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
MS patients can safely get infusions at home, new study shows
Disease control CompletedThis study looked at whether it is safe for people with multiple sclerosis to receive their natalizumab (Tysabri) infusions at home instead of at a hospital. Researchers compared serious side effects, quality of life, and costs over one year in 295 patients. The goal was to see i…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a weekend steroid pill stop vitiligo spreading in kids?
Disease control CompletedThis study tests whether taking dexamethasone pills twice a week for 3 months can stop active vitiligo from spreading in children aged 4 to 9. Researchers will also monitor side effects, especially on growth and bone health. The goal is to control the disease, not cure it.
Phase 4 • Sponsor: Cairo University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New insulin pump software tested in kids as young as 2
Disease control CompletedThis study is checking how safe and effective an updated insulin pump system (Control-IQ 1.5) is for children ages 2 to 6 with type 1 diabetes. About 144 kids will use the pump for a year while researchers track dangerous low blood sugar events and diabetic ketoacidosis. The goal…
Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New insulin set aims to last a full week for type 1 diabetes
Disease control CompletedThis study tests a new insulin infusion set designed to last up to 7 days for people with type 1 diabetes. Twenty adults currently using a Tandem insulin pump and Dexcom CGM will try the SteadiSet at home. The goal is to see if the set can survive a full week without causing high…
Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Gut health meets diet: a new angle on managing multiple sclerosis
Disease control CompletedThis trial tests whether adding a synbiotic supplement to a Mediterranean diet can improve quality of life and reduce disability in people with relapsing-remitting multiple sclerosis. Participants follow the diet for 12 weeks and take either a synbiotic or a placebo pill daily. R…
Sponsor: Hacettepe University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Better sleep, better blood sugar? a trial puts sleep coaching to the test
Disease control CompletedMany adults with type 1 diabetes don't get enough sleep, which can make blood sugar harder to control. This trial tests a 12-week program called Sleep-Opt that uses wearable sleep trackers, phone coaching, and educational materials to improve sleep habits. Researchers will measur…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a pill tame thyroid eye disease?
Disease control CompletedThis trial tests whether an oral medication called linsitinib can help people with active, moderate to severe thyroid eye disease, a condition that causes eye bulging and inflammation. Participants take either linsitinib or a placebo twice daily for 24 weeks. The main goal is to …
Phase 2/3 • Sponsor: Sling Therapeutics, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a berry extract tame type 1 diabetes?
Disease control CompletedThis trial tests whether a daily 10-gram dose of sea buckthorn extract, taken for 12 weeks, can improve blood sugar control and immune cell balance in adults with type 1 diabetes. Type 1 diabetes is an autoimmune condition where the body attacks insulin-producing cells. The study…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug aims to calm dangerous immune storms in Still's and lupus patients
Disease control CompletedThis study tested a drug called emapalumab in 33 children and adults with macrophage activation syndrome (MAS), a life-threatening immune overreaction, linked to Still's disease or lupus. The goal was to see if the drug could safely control the condition and reduce the need for h…
Phase 3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Two-Drug combo stop early rheumatoid arthritis in its tracks?
Disease control CompletedThis trial is testing whether combining certolizumab pegol, an injectable biologic, with methotrexate, a standard oral medication, can help adults with early active rheumatoid arthritis achieve and maintain remission. Participants are newly diagnosed, have not yet taken disease-m…
Phase 3 • Sponsor: UCB Pharma SA • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a Two-Drug combo quiet early rheumatoid arthritis for good?
Disease control CompletedThis trial tests whether combining certolizumab pegol (Cimzia) with methotrexate can help adults with early, active rheumatoid arthritis achieve and maintain low disease activity without flare-ups. Participants who already responded well to this combination in a prior study conti…
Phase 3 • Sponsor: UCB Pharma • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a virtual life-coach program help young adults tame type 1 diabetes?
Disease control CompletedThis study tests a telehealth program called REAL-T, designed to help young adults with type 1 diabetes fit diabetes care into their daily habits and routines. Participants receive about 12 hours of virtual coaching from an occupational therapist over six months. The study compar…
Sponsor: University of Southern California • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a blood flow drug help restore skin color in vitiligo?
Disease control CompletedThis trial tests whether a topical medication called pentoxifylline, typically used to improve blood flow, can help restore skin color in people with stable vitiligo. It compares this approach to another topical drug, 5-fluorouracil, and to microneedling alone, with all patients …
Sponsor: Tanta University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Second chance: new drug offers hope for thyroid eye disease Non-Responders
Disease control CompletedThis study tested an investigational drug called VRDN-001 in 143 people with thyroid eye disease who did not improve in earlier studies. The drug aims to reduce inflammation and eye bulging by blocking a specific receptor. Researchers measured how many participants had at least a…
Phase 3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis completed Phase 3 trial tested a drug called VRDN-001 in 231 people with thyroid eye disease (TED). The drug works by blocking a receptor involved in inflammation and swelling. The main goal was to check safety and tolerability, with secondary goals including measuring chang…
Phase 3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a targeted antibody calm thyroid eye disease?
Disease control CompletedThis trial tests whether veligrotug, an antibody that blocks a receptor involved in inflammation, can reduce eye bulging and swelling in people with active thyroid eye disease. Participants receive five infusions of the drug or a placebo. The study measures how many people see a …
Phase 3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Daily injection shows promise for Long-Term control of rare muscle disease
Disease control CompletedThis study tests the long-term safety and effectiveness of zilucoplan, a daily injection, in people with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. About 200 participants who completed a prior zilucoplan trial will receive the drug for an extend…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Smart insulin pump aims to end dangerous nighttime blood sugar swings
Disease control CompletedThis trial tests a smart insulin pump algorithm designed to automatically adjust insulin delivery during the night to keep blood sugar levels in a safe range. The algorithm predicts when blood sugar might drop too low and pauses insulin, and when it might rise too high, it gives …
Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a simple injection replace an IV for MS treatment?
Disease control CompletedThis study is testing whether a subcutaneous (under the skin) injection of ocrelizumab works as well as the standard intravenous (IV) infusion for people with relapsing or primary progressive multiple sclerosis. The trial will compare how the drug is absorbed, its safety, and its…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could less be more? testing whether kids can ease off arthritis meds
Disease control CompletedThis trial looks at whether children with juvenile spondyloarthritis who have stable, inactive disease can safely reduce or stop their TNFi medication without causing a flare. Participants are randomly assigned to continue their usual TNFi dose, take it less frequently, or stop i…
Phase 4 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
A smarter insulin that aims for the liver could curb dangerous nighttime dips
Disease control CompletedThis trial tests whether a specially designed mealtime insulin, HDV-insulin lispro, can reduce nighttime low blood sugar (hypoglycemia) in adults with type 1 diabetes. Participants will use continuous glucose monitors and work with doctors to adjust doses. One group receives the …
Phase 2 • Sponsor: Diasome Pharmaceuticals • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a pill calm the immune attack in MS? a trial looks inside the spinal fluid
Disease control CompletedThis trial tests whether cladribine tablets change key immune cells and nerve damage markers in the spinal fluid of people with relapsing forms of multiple sclerosis. Participants take cladribine as prescribed and undergo up to two lumbar punctures to measure these biomarkers ove…
Phase 4 • Sponsor: Gregory Wu • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a once-daily pill tame psoriatic arthritis in everyday life?
Disease control CompletedThis study tracks about 450 adults with active psoriatic arthritis who are prescribed upadacitinib (RINVOQ) by their doctor. Researchers will follow participants for up to 24 months to see how well the drug controls joint and skin symptoms when used alone or with methotrexate in …
Sponsor: AbbVie • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can filgotinib safely control rheumatoid arthritis over years? a large trial seeks answers.
Disease control CompletedThis trial is testing the long-term safety and tolerability of the drug filgotinib in people with rheumatoid arthritis who have already completed an earlier filgotinib study. Researchers are monitoring side effects, lab abnormalities, and vital signs over an extended period. The …
Phase 3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat psoriatic arthritis
Disease control CompletedThis study tested whether combining two drugs (guselkumab and golimumab) works better than one drug alone for people with active psoriatic arthritis who didn't get enough relief from previous TNF-alpha blockers. 91 adults took part. The goal was to see if the combo could help mor…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug bimekizumab shows promise for psoriatic arthritis in phase 3 trial
Disease control CompletedThis Phase 3 trial tested bimekizumab, a drug given by injection, against a placebo in 400 adults with active psoriatic arthritis who had not responded well to TNF-alpha inhibitors. The study aimed to see if bimekizumab could reduce joint pain and swelling and improve daily funct…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug shows promise for controlling psoriatic arthritis symptoms
Disease control CompletedThis study tested a drug called bimekizumab in 852 adults with active psoriatic arthritis, a condition causing joint pain, swelling, and skin patches. Participants received either bimekizumab, a placebo, or an existing treatment (adalimumab). The main goal was to see if bimekizum…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Gentler transplant shows promise for kids with blood diseases
Disease control CompletedThis study tests a milder chemotherapy and immune-suppressing regimen before a stem cell transplant for children and young adults with non-malignant blood disorders like sickle cell disease or immune deficiencies. The goal is to safely achieve donor cell engraftment with fewer si…
Phase 2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Carb showdown: which diet best controls type 1 diabetes?
Disease control CompletedThis study tests how different amounts of dietary carbohydrates affect insulin needs and blood sugar control in adults with type 1 diabetes. Participants are randomly assigned to one of three diets: a traditional diet with 50-60% of calories from carbs, a moderately low-carb diet…
Sponsor: Anneli Björklund • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New biologic drug aims to ease joint pain and swelling in Tough-to-Treat psoriatic arthritis
Disease control CompletedThis phase 3 trial tests whether risankizumab, an injectable biologic, can reduce joint pain and swelling in adults with moderately to severely active psoriatic arthritis who have not responded to or cannot tolerate other biologic treatments. Participants receive either risankizu…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a peer coach help young people take control of their chronic illness?
Disease control CompletedThis study tests whether a peer coaching program delivered by phone and text can help adolescents and young adults (ages 16–22) with chronic conditions like sickle cell disease, diabetes, or cystic fibrosis improve their self-management skills. Participants are paired with a trai…
Sponsor: Duke University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Low-carb diet may help type 1 diabetes patients keep making some insulin
Disease control CompletedThis study tests whether a low-carbohydrate diet (under 75 grams per day) can help adults with type 1 diabetes preserve their remaining insulin production. The idea is that the diet might calm the immune attack on insulin-making cells. Participants will follow the diet for a peri…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Rheumatoid arthritis drug safety showdown: baricitinib vs. TNF inhibitors
Disease control CompletedThis study compares the safety of baricitinib, an oral medication, against TNF inhibitors (injectable drugs like etanercept and adalimumab) in people with rheumatoid arthritis. The main focus is on the risk of venous thromboembolism (blood clots in veins). Participants include th…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a four-week program boost diabetes tech use in teens?
Disease control CompletedThis study tests a four-week virtual program designed to help teens aged 12-21 with type 1 diabetes use technology like insulin pumps and continuous glucose monitors. Participants complete surveys and interviews about their diabetes management and technology use. The goal is to u…
Sponsor: Stanford University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a wearable sensor help young people with type 1 diabetes tame blood sugar swings?
Disease control CompletedThis study tests whether using a continuous glucose monitor (CGM) — a small sensor that tracks blood sugar levels in real time — helps teens and young adults (ages 14 to under 25) with type 1 diabetes improve their blood sugar control compared to standard fingerstick testing. Par…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Brain-like software upgrade helps insulin pumps outsmart diabetes
Disease control CompletedThis study tests a software upgrade for an automated insulin pump system (Control-IQ) in adults with type 1 diabetes. The upgrade adds an adaptive biobehavioral control module that learns from the user's patterns to improve blood sugar management. Participants use the standard sy…
Sponsor: Sue Brown • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Fish oil for eyes: Omega-3s tested against diabetic retinopathy
Disease control CompletedThis completed trial tested whether daily omega-3 fish oil supplements can help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. 82 participants took either a 1000 mg omega-3 capsule or a placebo for the study, with regular eye exams to monitor retinal c…
Sponsor: University of Faisalabad • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Your plate may fight psoriatic arthritis: diet study tests food as medicine
Disease control CompletedThis study investigates whether changing diet can reduce disease activity in people with psoriatic arthritis. Participants are randomly assigned to one of two diets: one focusing on which foods are eaten, and another limiting daily calorie intake. The trial lasts 24 weeks and inc…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Rheumatoid arthritis drug baricitinib put to the test against TNF blockers in major safety trial
Disease control CompletedThis completed Phase 4 study compared the safety of baricitinib (a daily pill) to TNF inhibitors (injections) in over 2,600 adults with rheumatoid arthritis. The main goal was to see if baricitinib had a higher risk of blood clots. Participants had to be at least 60, have a histo…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Short exercise program may cut heart risk in arthritis patients
Disease control CompletedThis completed study tested whether a 6-week cardiac rehabilitation program (aerobic and resistance exercises) could improve heart disease risk, blood pressure, and arthritis activity in 40 people with both rheumatoid arthritis and high blood pressure. Participants were randomly …
Sponsor: Kayseri City Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Baking soda may cut kidney risk in type 1 diabetes
Disease control CompletedThis study tested whether taking two doses of sodium bicarbonate (baking soda) over 24 hours could reduce uric acid crystals in the urine of adults with type 1 diabetes. Uric acid crystals can harm the kidneys, so lowering them might help prevent diabetic kidney disease. The tria…
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
MS treatment showdown: which drug wins on cost and disability?
Disease control CompletedThis study looked at 144 people with aggressive relapsing multiple sclerosis to compare two treatment plans over three years: monthly natalizumab infusions versus a six-month course of mitoxantrone followed by another immune-modulating drug. Researchers measured cost-effectivenes…
Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a drug plus light therapy reverse vitiligo? new trial tests the combo
Disease control CompletedThis phase 2 trial tested whether adding the oral drug baricitinib to phototherapy (light treatment) helps restore skin color in adults with progressive vitiligo. 49 participants received either baricitinib plus phototherapy or a placebo plus phototherapy for 36 weeks. The main g…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could your own blood cells tame MS? early trial shows promise
Disease control CompletedThis early-phase trial tested a new treatment for relapsing-remitting multiple sclerosis (RRMS) that uses a patient's own red blood cells. The cells are coated with specific peptides and given back to the patient to teach the immune system to stop attacking the body. The study in…
Phase 1 • Sponsor: Cellerys AG • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New lupus drug shows promise in early safety trial
Disease control CompletedThis early-stage trial tested a drug called itolizumab (EQ001) in 52 adults with lupus, some of whom also had active kidney inflammation. The main goal was to check safety and find the right dose. Researchers also looked at how the drug behaves in the body and how it affects immu…
Phase 1 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Real-World lupus study reveals how new drug performs outside clinical trials
Disease control CompletedThis study looked at 152 adults with systemic lupus erythematosus (SLE) who started taking anifrolumab during its first year on the market in Spain. Researchers tracked their disease activity, flare-ups, and remission rates using standard medical records. The goal was to see how …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a blood flow drug ease painful finger ulcers in scleroderma?
Disease control CompletedThis study tested the drug bosentan in 18 adults with systemic sclerosis who had reduced blood flow in their hands and a history of digital ulcers. The goal was to see if bosentan could improve hand blood flow measured by laser imaging and how blood flow relates to ulcer severity…
Phase 4 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
AI boosts insulin timing for better diabetes control
Disease control CompletedThis study tested whether adding a smart, AI-powered insulin boost before meals could improve blood sugar control in adults with type 1 diabetes. Nineteen participants used either a standard automated insulin system or the same system with the AI boost during hotel stays and at h…
Sponsor: Sue Brown • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin
Disease control CompletedThis study tested whether the drug rivaroxaban works as well as warfarin to prevent further brain damage in people who have had a stroke due to antiphospholipid syndrome (APS), a condition that causes abnormal blood clotting. About 40 participants took either rivaroxaban or warfa…
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a common arthritis drug help stop vitiligo from spreading?
Disease control CompletedThis phase 2 trial tested whether adding methotrexate (a drug used for arthritis) to standard UVB light therapy works better than light therapy alone for adults with active, spreading vitiligo. Thirty-two participants were randomly assigned to receive either methotrexate pills pl…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Daily painkillers may shield spines in arthritis patients on biologics
Disease control CompletedThis study looked at whether taking NSAIDs every day, instead of only when needed, can prevent spine damage in people with ankylosing spondylitis who are also receiving anti-TNF therapy. 188 adults participated in this Phase 3 trial. The goal was to see if continuous NSAID use re…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a common supplement help tame multiple sclerosis?
Disease control CompletedThis study tested whether a dietary supplement called propionic acid is safe and helpful for people with multiple sclerosis (MS). Twenty-two adults with stable MS took propionic acid capsules alongside their usual MS medications. Researchers measured nerve damage markers and thin…
Phase 2/3 • Sponsor: Salzburger Landeskliniken • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Oral MS drug shows promise for kids in landmark trial
Disease control CompletedThis completed Phase 3 trial tested the oral drug dimethyl fumarate (Tecfidera) against an injected interferon in 156 children aged 10 to 17 with relapsing-remitting multiple sclerosis. The main goal was to see if the drug could prevent new brain lesions and control the disease s…
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a common blood pressure drug slow type 1 diabetes?
Disease control CompletedThis study tested whether verapamil, a drug usually used for high blood pressure, can help preserve insulin-making cells in adults newly diagnosed with type 1 diabetes. 136 participants received either verapamil or a placebo for 12 months. The main goal was to see if verapamil co…
Phase 2 • Sponsor: Medical University of Graz • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Rituximab shows promise for long-term control of rare blistering skin disease
Disease control CompletedThis study followed 80 patients with pemphigus, a rare autoimmune disease that causes painful blisters on skin and mucous membranes. Researchers wanted to see how safe and effective rituximab (a drug that targets certain immune cells) is over the long term, compared to standard h…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug shows promise for Sjögren's syndrome in Mid-Stage trial
Disease control CompletedThis Phase 2 trial tested a drug called CFZ533 (iscalimab) in 273 adults with Sjögren's syndrome, an autoimmune disease causing dryness, pain, and fatigue. Participants received either the drug or a placebo for 24 weeks. The study measured changes in disease activity and symptoms…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Melatonin may boost brain and blood sugar health in teens with diabetes
Disease control CompletedThis study tested whether taking a melatonin supplement (3 mg each night for 6 months) could improve sleep, thinking skills, and blood sugar control in 70 adolescents with type 1 diabetes. Half received melatonin and half received a placebo. The researchers measured changes in bl…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New lupus pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested an oral medication called GLPG3667 in 186 adults with active systemic lupus erythematosus (SLE). Participants took the drug or a placebo once daily for 48 weeks. The goal was to see if the drug could reduce lupus disease activity and improve symptoms, while moni…
Phase 2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Cancer drug shows promise for rare skin disease
Disease control CompletedThis study tested whether imatinib, a drug used for certain cancers, can reduce skin hardening in people with severe scleroderma. 28 adults received either imatinib or a placebo for 6 months. The main goal was to see if the drug improved skin thickness and quality of life.
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a viagra drug heal scleroderma finger sores?
Disease control CompletedThis study tested whether sildenafil (the drug in Viagra) can help heal painful finger ulcers in people with scleroderma, a disease that damages blood vessels. 84 participants took either sildenafil or a placebo three times daily for 90 days. The main goal was to see if the ulcer…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a probiotic help celiac hearts? new study explores cholesterol reduction
Disease control CompletedThis study looked at whether a probiotic called LP-LDL can lower cholesterol and improve heart health in adults with celiac disease. 50 participants took the probiotic to see if it reduced their cholesterol levels and body mass index. The goal was to find a safe way to manage hea…
Sponsor: University of Roehampton • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New tech aims to prevent low blood sugar in seniors with diabetes
Disease control CompletedThis study tested whether an enhanced continuous glucose monitor (eCGM) linked to a decision-support system can help older adults (65+) with type 1 diabetes manage their blood sugar. The system automatically uploads glucose, insulin, and activity data to give personalized insulin…
Sponsor: Joslin Diabetes Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Blood filtering therapy shows promise for MS in early trial
Disease control CompletedThis study tested a treatment called extracorporeal photopheresis (ECP) in 15 people with multiple sclerosis. ECP is a procedure that filters a person's blood, treats it with light, and returns it to the body. The goal was to see if it is safe and if it can improve walking, hand …
Phase 1/2 • Sponsor: Abu Dhabi Stem Cells Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
App aims to help teens tame tough diabetes
Disease control CompletedThis small pilot study tested whether a remote digital care program (TELEDUC-DIAB) could help 10 teens aged 12-17 with poorly controlled type 1 diabetes. Participants used a monitoring platform and educational app alongside their usual care. The main goal was to see if their bloo…
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can a blood vessel drug save kidneys in scleroderma crisis?
Disease control CompletedThis study tested a drug called bosentan in 16 adults with scleroderma who had a serious kidney complication called scleroderma renal crisis. The goal was to see if bosentan could help protect kidney function and improve survival over 6 months to a year. The drug works by blockin…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New study tests easier treatment for blistering skin disease
Disease control CompletedThis study tested two ways to treat bullous pemphigoid, a severe blistering skin condition. One group used strong steroid creams for 9 months, while the other used steroids plus methotrexate for 4 weeks, then methotrexate alone for 8 months. The goal was to see if the combination…
Phase 3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New insulin system helps kids with diabetes keep blood sugar in check
Disease control CompletedThis study looked at how well the TouchCare Nano automated insulin delivery system works for children and teens with type 1 diabetes in everyday life. Researchers tracked 76 kids aged 6 to 18 over six months to see if the system helped them spend more time with healthy blood suga…
Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eye procedure shows promise for kids with glaucoma after cataract surgery
Disease control CompletedThis study tested a minimally invasive surgery called GATT in 30 children who developed glaucoma after cataract surgery. The procedure aims to lower eye pressure by improving fluid drainage inside the eye. Researchers measured changes in eye pressure and the number of glaucoma me…
Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a lupus drug shield organs from Long-Term harm?
Disease control CompletedThis study looked at whether the drug anifrolumab, when added to standard lupus treatments, can reduce long-term organ damage compared to standard care alone. Researchers analyzed data from 561 adults with active lupus, comparing those who took anifrolumab in earlier trials to si…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with lupus: drug trial shows promise
Disease control CompletedThis study tested the drug belimumab in children aged 5 to 17 with active lupus. Participants received either belimumab or a placebo alongside their usual treatments. The goal was to see if belimumab could safely reduce lupus disease activity over 52 weeks.
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New psoriasis drug shows promise in major trial
Disease control CompletedThis study tested a new drug called bimekizumab in 567 adults with moderate to severe plaque psoriasis. Participants received either bimekizumab, a placebo, or another active drug. The main goal was to see how well bimekizumab cleared skin lesions after 16 weeks. Results showed s…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Swiss study reveals Real-World impact of MS drug kesimpta
Disease control CompletedThis study followed 107 adults in Switzerland with relapsing multiple sclerosis who were already taking Kesimpta (ofatumumab) as part of their routine care. Researchers tracked how many patients had no signs of disease activity, including relapses, new brain lesions, or worsening…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
One-Dose hope for blistering skin disease?
Disease control CompletedThis study tested whether a single cycle of rituximab can control bullous pemphigoid, a severe blistering skin condition. Eighteen adults with steroid-dependent or relapsing disease were enrolled. Researchers checked disease control weekly for a month and then monthly for two yea…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Ultrasound may spot arthritis Flare-Ups before symptoms start
Disease control CompletedThis study tested whether ultrasound could detect signs of rheumatoid arthritis (RA) relapse before symptoms appear in patients treated with rituximab. Thirty adults with RA who had not responded to at least one TNF-blocking drug were included. Researchers used ultrasound to meas…
Phase 4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Smart insulin pump beats daily shots in diabetes trial
Disease control CompletedThis study tested whether the Omnipod 5, a tubeless automated insulin pump, works better than multiple daily insulin injections for managing type 1 diabetes. 189 children and adults participated. The main goal was to see if the pump improved blood sugar control (HbA1c) over 13 we…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Smart insulin pump aims to reduce dangerous lows in type 1 diabetes
Disease control CompletedThis study followed 30 adults with type 1 diabetes who used the Smartguard system, a partially automated insulin pump that can pause insulin delivery when it predicts a low blood sugar. The goal was to see how well the system works in everyday life, focusing on time spent in the …
Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New tool helps parents of diabetic tots tame blood sugar
Disease control CompletedThis study tested a special educational tool for parents of children under 6 with type 1 diabetes. The goal was to see if the tool could help parents better control their child's blood sugar and prevent serious events like low blood sugar or ketosis. The study enrolled 24 childre…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Video game teaches diabetic kids to manage disease
Disease control CompletedThis study tested whether a serious computer game called DIVE helps children aged 10-17 with newly diagnosed type 1 diabetes learn about their disease. 78 kids played the game twice a week for at least an hour, covering topics like diet and treatment. Researchers measured their k…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
App-Based education boosts diabetes Self-Care in teens
Disease control CompletedThis study tested a mobile app that teaches teenagers with type 1 diabetes how to better manage their condition. 96 teens aged 12-18 were split into two groups: one used the app, the other received standard care. Researchers measured changes in diabetes knowledge, self-confidence…
Sponsor: Deniz Akkaya Balcı • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Texting teens to tame diabetes: simple SMS shows promise
Disease control CompletedThis study tested whether sending supportive text messages to teenagers with poorly controlled type 1 diabetes could help lower their blood sugar levels. 92 teens aged 12-21 with high HbA1c levels participated. The approach used mobile phone reminders to encourage better diabetes…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a daily aspirin protect diabetic Moms-to-Be?
Disease control CompletedThis study tested whether taking low-dose aspirin (150 mg) daily, starting in the first trimester, could reduce pregnancy complications in women with type 1 or type 2 diabetes. The trial included 137 women and looked at outcomes like preeclampsia, early preterm birth, low birth w…
Phase 3 • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a pill plus light therapy restore skin color in vitiligo?
Disease control CompletedThis study tested whether the drug apremilast, taken as a pill twice daily, combined with narrowband UVB light therapy can help restore skin color in people with widespread vitiligo. 80 adults with stable or slowly progressing vitiligo covering at least 10% of their body took par…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New antibody shows promise for blistering skin disease
Disease control CompletedThis phase 2 trial tested avdoralimab, an antibody that blocks a specific immune signal, added to standard steroid cream for bullous pemphigoid—a severe blistering skin condition mostly affecting older adults. Fifteen participants received the combination to see if it leads to co…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Stem cell transplant shows promise for scleroderma patients
Disease control CompletedThis study compared two treatment strategies for people with early, severe scleroderma: a stem cell transplant using their own cells versus standard immunosuppressive drugs. The trial enrolled 60 adults with diffuse cutaneous systemic sclerosis. The goal was to see which approach…
Phase 4 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study: can upadacitinib ease back pain in axial spondylarthritis?
Disease control CompletedThis study looked at how well upadacitinib, an anti-inflammatory pill, controls pain in people with axial spondylarthritis (axSpA), a condition causing chronic back pain. Over 700 adults from 19 countries took the drug as prescribed by their doctors and were followed for 12 month…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a stricter setting on an artificial pancreas improve blood sugar control?
Disease control CompletedThis study tested whether using a very tight glucose target (80-99 mg/dL) in an advanced hybrid closed-loop insulin pump (CamAPS FX) improves blood sugar control in adults with type 1 diabetes who had poor control. Forty participants who previously used multiple daily injections …
Sponsor: Castilla-La Mancha Health Service • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New app could help children with diabetes avoid dangerous blood sugar swings
Disease control CompletedThis pilot study tested DiaBuddy, a mobile app designed to help children with type 1 diabetes and their families make better decisions about insulin dosing and managing sick days. Twenty-five children aged 5 to 18 used the app for three months. The study found that the app's reco…
Sponsor: Regency Hospital Kanpur • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Smart insulin pumps put to the test in everyday life
Disease control CompletedThis study followed 410 people with type 1 diabetes who use closed-loop insulin pumps—devices that automatically adjust insulin delivery. Researchers measured how well these pumps control blood sugar over time using HbA1c levels. The goal was to see if the pumps work effectively …
Sponsor: Groupe Hospitalier de la Rochelle Ré Aunis • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a parathyroid gland help cure diabetes? small trial tests Co-Transplant
Disease control CompletedThis small pilot study tested whether transplanting pancreatic islets together with parathyroid glands into the muscle could help people with type 1 diabetes stop using insulin. The 4 participants already had a functioning kidney or liver transplant and were on lifelong immunosup…
Phase 1/2 • Sponsor: Peter Stock • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
One donor, two transplants: could this end lifelong Anti-Rejection drugs?
Disease control CompletedThis pilot study tested a combined bone marrow and kidney transplant from a partially matched family donor in 10 people with both a blood disorder and chronic kidney disease. The goal was to treat both conditions at once and possibly reduce the need for lifelong anti-rejection dr…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can a monthly injection stop MS in its tracks? new study aims to find out
Disease control CompletedThis study tested a monthly injection of ofatumumab in 180 people with very early relapsing-remitting multiple sclerosis (MS). The goal was to see if the drug could stop all signs of disease activity—like relapses, disability worsening, and new brain lesions—over 18 months. Resea…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a daily pill bring back skin color? new trial tests ritlecitinib for vitiligo
Disease control CompletedThis Phase 3 study tested ritlecitinib, an oral drug, in 607 adults and adolescents with nonsegmental vitiligo (a type of white patches on the skin). Participants took either the drug or a placebo daily for 52 weeks. The main goals were to see if the drug could improve skin color…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New pill shows promise for treating spinal arthritis in large trial
Disease control CompletedThis study tested a daily pill called upadacitinib in 734 adults with axial spondyloarthritis, a type of arthritis that causes pain and stiffness in the spine. The drug was compared to a placebo to see if it could reduce symptoms and control the disease. Results showed that upada…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sjögren's drug shows promise in safety extension trial
Disease control CompletedThis study looked at the long-term safety of efgartigimod in 24 adults with primary Sjögren's syndrome who had already completed a prior trial. Efgartigimod works by lowering certain antibodies that may drive the disease. The main goal was to track side effects over 48 weeks, wit…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New MS drug combo shows promise in early trial
Disease control CompletedThis study tested an experimental drug called BIIB091, alone or combined with an approved MS drug (diroximel fumarate), in 127 people with relapsing multiple sclerosis. The goal was to check safety and see if it reduces brain inflammation on MRI scans. Participants took pills twi…
Phase 2 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New insulin boosts artificial pancreas performance in type 1 diabetes trial
Disease control CompletedThis study tested whether a faster-acting insulin (Lyumjev) works better than standard insulin (Humalog) in a dual-hormone artificial pancreas for people with type 1 diabetes. Twelve adults who already used the artificial pancreas took part. Each person used both insulins for 30 …
Sponsor: Inreda Diabetic B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for autoimmune hepatitis patients who fail standard treatment
Disease control CompletedThis study tested a new biologic drug called VAY736 in 68 adults with autoimmune hepatitis who did not get better with or could not tolerate standard treatments. The goal was to see if VAY736 could safely help normalize liver enzyme levels. Participants received either VAY736 or …
Phase 2/3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a Vaccine-Like shot tame type 1 diabetes?
Disease control CompletedThis early-stage study tested a new treatment called IBC with MAS-1 in 21 adults recently diagnosed with type 1 diabetes. The goal was to see if it is safe and can retrain the immune system to stop attacking the pancreas, potentially helping the body control blood sugar naturally…
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Low-Dose rituximab shows promise for blood disorder
Disease control CompletedThis study tested two low-dose rituximab schedules in 100 adults with immune thrombocytopenia (ITP), a condition causing low platelet counts and bleeding. The goal was to see which regimen better raises platelets and controls bleeding. Participants had failed or relapsed on stand…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
One laser session may be as safe as four for diabetic eyes
Disease control CompletedThis study looked at 83 people with diabetes and early-stage eye disease. It compared having laser treatment in one session versus four sessions to see which approach better controls the disease and reduces the risk of swelling in the center of the eye. The main goal was to measu…
Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Head-to-Head: which drug works better for psoriatic arthritis in the real world?
Disease control CompletedThis study looked at 70 people with psoriatic arthritis to compare two drug types: upadacitinib and IL-17 inhibitors. Researchers tracked joint and skin symptoms over 24 weeks in routine care. The goal is to see which works better in real life, helping doctors personalize treatme…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug shows promise for Long-Term control of rare Muscle-Weakening disease
Disease control CompletedThis study tested the long-term safety of efgartigimod injections in 184 people with generalized myasthenia gravis, a chronic disease that causes muscle weakness. Participants received repeated treatment cycles over time. The goal was to see if the drug is safe and tolerable when…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could an arthritis drug ease Sjögren's symptoms?
Disease control CompletedThis study tested whether tocilizumab, a drug that blocks inflammation, can help people with primary Sjögren's syndrome—an autoimmune disease causing dry eyes, dry mouth, pain, and fatigue. Researchers gave 110 participants either tocilizumab or a placebo to see if it could reduc…
Phase 2/3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Which biologic works best after Anti-TNF failure? study seeks answers
Disease control CompletedThis study looked at 300 adults with active rheumatoid arthritis whose first anti-TNF treatment stopped working. Researchers compared two strategies: switching to a different type of biologic drug or trying a second anti-TNF. The goal was to see which approach better controls the…
Phase 4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Artificial pancreas with two hormones could ease diabetes management
Disease control CompletedThis study tested a fully automated system that delivers both insulin and glucagon to manage blood sugar in adults with type 1 diabetes. Over 12 months, 243 participants used either the dual-hormone device or their usual care. The goal was to see if the system helps keep blood su…
Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Biosimilar switch works for most patients in Real-World study
Disease control CompletedThis study tested what happens when patients with rheumatoid arthritis, Crohn's disease, or eye inflammation switch from the original drug Remicade to its lower-cost biosimilar Inflectra. Over 260 adults who had been on Remicade for at least 4 months were switched. The main goal …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New injection aims to retrain immune cells to fight arthritis
Disease control CompletedThis early study tested a new drug called EF-M2 (Immutalon) in 48 adults with moderate-to-severe rheumatoid arthritis. The drug is designed to shift immune cells from a pro-inflammatory to an anti-inflammatory state. Participants received injections for 4 weeks, and researchers m…
Phase 1/2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
MS patients may ditch IV drips for At-Home shots
Disease control CompletedThis study looked at whether people with relapsing multiple sclerosis can safely switch from an intravenous (IV) anti-CD20 antibody treatment to a self-injected drug called ofatumumab. 111 adults took part, and researchers tracked their brain scans and side effects for a year. Th…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Sleep coaching shows promise for blood sugar control in young diabetics
Disease control CompletedThis study tested whether a sleep coaching program could help young adults (ages 18-26) with type 1 diabetes sleep longer and improve their blood sugar levels. Participants received personalized sleep advice and weekly check-ins over several weeks. The goal was to see if better s…
Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New daily pill shows promise for rheumatoid arthritis in early trial
Disease control CompletedThis Phase 2 trial tested Proximod, a daily pill that calms the immune system, in 179 adults with moderate-to-severe rheumatoid arthritis who had not responded well to standard treatments. Participants took either 5 mg, 10 mg, or a placebo daily for three months, with one month o…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Cord blood cells injected into spine show promise for MS
Disease control CompletedThis early-stage trial tested a new cell therapy called DUOC-01, made from donated umbilical cord blood, in 20 adults with primary progressive multiple sclerosis (PPMS). The cells were injected into the spinal fluid to see if it was safe. Researchers also looked for early signs o…
Phase 1 • Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug shows promise in slowing progressive MS disability
Disease control CompletedThis Phase 3 trial tested whether the oral drug tolebrutinib can delay disability progression in people with primary progressive multiple sclerosis (PPMS). 767 adults with PPMS received either tolebrutinib or a placebo. The study measured time to confirmed disability worsening ov…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Spanish study checks Real-World use of MS drug ofatumumab
Disease control CompletedThis completed study in Spain looked at 310 people with relapsing multiple sclerosis who were taking ofatumumab (Kesimpta®). Researchers wanted to see how well the drug reduced relapses and how safe it was in everyday medical practice. The study collected information from medical…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug shows promise for back pain from ankylosing spondylitis
Disease control CompletedThis study tested a drug called bimekizumab in 332 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either the drug or a placebo injection. The goal was to see if the drug could reduce symptoms like pain and…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a drug duo save insulin-making cells in type 1 diabetes?
Disease control CompletedThis study tested whether combining two safe immune therapies—abatacept injections and nasal insulin—can help preserve the pancreas's ability to make insulin in people recently diagnosed with type 1 diabetes. The goal is to make blood sugar control easier and reduce the need for …
Phase 2 • Sponsor: Melbourne Health • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Phone coaching helps kids with diabetes manage blood sugar better
Disease control CompletedThis study tested a personalized telemedicine coaching program for children with type 1 diabetes who have difficulty adjusting their insulin therapy. Over 100 children received phone and secure message coaching from nurses for 6 months. The goal was to improve blood sugar control…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug may shield celiac patients from gluten damage
Disease control CompletedThis study tested a drug called KAN-101 in 55 adults with celiac disease who had been on a gluten-free diet for at least a year. Participants received either KAN-101 or a placebo, then underwent a two-week gluten challenge. The drug appeared to reduce gluten-induced damage to the…
Phase 2 • Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Peer power: mentors help young diabetics navigate adult care
Disease control CompletedThis study tested whether trained peer mentors (ages 20-35) could help young adults (ages 17-25) with type 1 diabetes better control their blood sugar and smoothly move from pediatric to adult diabetes care. 144 participants were randomly assigned to receive peer support or usual…
Phase 2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
App-Based workouts may cut insulin needs for diabetic kids
Disease control CompletedThis study tested a mobile app called Diactive-1 that guides children and teens with type 1 diabetes through resistance exercises like squats and band pulls. Over 24 weeks, researchers tracked whether the app helped lower daily insulin doses. The trial enrolled 62 participants ag…
Sponsor: Fundacion Miguel Servet • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Before or after? study tests best time for insulin in type 1 diabetes
Disease control CompletedThis study looked at whether taking a fast-acting insulin (Insulin Aspart) before or after meals makes a difference in blood sugar control for people with type 1 diabetes who use an insulin pump. Twenty-two adults participated, and their blood sugar was tracked continuously for 1…
Phase 3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Weekly insulin shot could replace daily injections for type 1 diabetes
Disease control CompletedThis study compares a new once-weekly insulin (icodec) to a standard daily insulin (degludec) in 582 adults with type 1 diabetes. Participants receive either weekly or daily injections, plus mealtime insulin, for about a year. The goal is to see if the weekly option controls bloo…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Massive study tests everyday supplements against autoimmune disease and aching knees
Disease control CompletedThis large study looked at whether taking daily vitamin D or fish oil supplements could lower the risk of developing autoimmune diseases (like rheumatoid arthritis), reduce signs of inflammation in the blood, and ease chronic knee pain. Over 25,000 adults without prior cancer or …
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Spit test aims to spot Sjögren's disease without a biopsy
Diagnosis CompletedResearchers are studying whether cell-free RNA in saliva can work as a non-invasive liquid biopsy to help diagnose Sjögren's disease. The trial compares saliva from people with Sjögren's disease against saliva from people with dry-eye and dry-mouth symptoms who do not have the di…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
One scan, two images: new MRI technique could cut MS brain exam time
Diagnosis CompletedThis study tests a new MRI technique called ENRAGED FLAIR that aims to capture two types of brain images (T2-FLAIR and T1-weighted) in a single sequence, instead of the usual two separate scans. Researchers will compare the image quality and time savings against standard MRI in 1…
Sponsor: Region Stockholm • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Could diabetes be silently damaging your hearing?
Diagnosis CompletedThis study investigates whether hearing problems are an under-recognized complication of diabetes. Researchers will screen 172 adults with type 1 or type 2 diabetes using hearing tests and a questionnaire. If a hearing issue is found, a more detailed assessment will be done to de…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
New fingerstick test for blood thinner monitoring put to the test
Diagnosis CompletedThis study tested how well a small, portable device (LumiraDx) measures blood clotting (INR) compared to standard lab tests. Researchers collected blood from 420 adults, some taking warfarin and some not, using both a fingerstick and a vein draw. The goal was to see if the device…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Can a tablet Eye-Tracker replace the Neurologist's exam for MS?
Diagnosis CompletedThis study tested whether a tablet-based eye-tracking device (ETNA-MS) can accurately estimate disability levels in people with Multiple Sclerosis. Sixty adults with MS took eye-tracking tests, and the device's estimates were compared to standard neurologist assessments. The goal…
Sponsor: Innodem Neurosciences • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New blood and urine tests could spot Drug-Related pancreatitis early
Diagnosis CompletedThis study looked at new markers in blood and urine to detect and predict the severity of drug-associated acute pancreatitis in adults. Researchers compared these markers in 175 patients with drug-induced pancreatitis, other pancreatic diseases, and healthy volunteers. The goal i…
Sponsor: University of Liverpool • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Could a 6-Meter walk test replace the standard for MS patients?
Diagnosis CompletedThis study looked at whether a 6-minute walk test done over a short 6-meter distance is a valid and reliable way to measure walking ability in people with multiple sclerosis. Twenty-one adults with MS participated. The goal is to see if this shorter version works as well as the s…
Sponsor: Haute Ecole de Santé Vaud • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
New MRI technique could sharpen MS diagnosis
Diagnosis CompletedThis study tested two different MRI scanning methods to see which better detects the 'central vein sign' in the brains of people with multiple sclerosis (MS). The central vein sign is a marker that helps doctors diagnose MS more accurately. Sixty adults with early-stage MS underw…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
New MRI technique could sharpen detection of active MS lesions
Diagnosis CompletedThis study tested two different MRI sequences to see which one better detects active inflammatory lesions in the brains of people with multiple sclerosis (MS). 180 adults with known central nervous system inflammatory disease who needed an MRI after a recent clinical event took p…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Ultrasound could spot deadly lung disease in scleroderma patients early
Diagnosis CompletedThis study tested whether a painless, non-radiation ultrasound of the chest can find early signs of lung scarring in people with scleroderma. Thirty patients without known lung disease on CT scans underwent thoracic ultrasound. The goal was to see how often ultrasound detects hid…
Sponsor: University Hospital, Tours • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Can a group program stop eating disorders in type 1 diabetes?
Prevention CompletedResearchers at Stanford University are testing whether the Diabetes Body Project, a six-session group program, can reduce eating disorder symptoms and improve blood sugar control in young women with type 1 diabetes. The study enrolls 55 female-identifying participants aged 15 to …
Sponsor: Stanford University • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Probiotics show promise in stopping autoimmune diseases before they start
Prevention CompletedThis study tested whether giving a daily mix of two types of friendly bacteria (Lactobacilli) to children at genetic risk could prevent or slow down autoimmune diseases like celiac disease, type 1 diabetes, and thyroid problems. The researchers enrolled 202 children who already h…
Sponsor: Lund University • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Can a wrinkle treatment calm a rare, painful skin disease?
Symptom relief CompletedHailey-Hailey and Darier disease are rare inherited skin conditions that cause painful, itchy lesions in skin folds. Sweating makes them worse, and standard treatments often do not work well. Researchers are testing whether botulinum toxin injections into large skin folds can red…
Phase 1 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Ancient cupping technique tested for back pain relief
Symptom relief CompletedThis study tested whether wet cupping therapy, an ancient practice where small cuts are made on the skin and cups are used to draw out a small amount of blood, can help people with ankylosing spondylitis, a type of arthritis that mainly affects the spine. Half of the 100 particip…
Sponsor: Karabuk University • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Can exercise rebuild muscle and balance in MS?
Symptom relief CompletedResearchers are testing whether a combined exercise program can improve muscle thickness, balance, and fall risk in people with multiple sclerosis who also have sarcopenia, a condition involving loss of muscle mass and strength. Participants in the exercise group attend 60-minute…
Sponsor: Uskudar University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can taekwondo kicks ease ankylosing spondylitis?
Symptom relief CompletedResearchers are testing whether a 12-week Taekwondo training program can help adults with ankylosing spondylitis and axial spondyloarthritis. The trial enrolls 21 adults aged 19 to 59 who have stable treatment or no medication for at least three months. Participants join either a…
Sponsor: Wonju Severance Christian Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can diet ease the crushing fatigue of multiple sclerosis?
Symptom relief CompletedResearchers are comparing two diets to see whether either one reduces fatigue in people with relapsing-remitting multiple sclerosis. Participants follow their usual diet for 12 weeks, then are randomly assigned to the Swank low-saturated-fat diet or the Wahls Elimination modified…
Sponsor: Terry L. Wahls • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can home workouts match In-Person therapy for MS?
Symptom relief CompletedResearchers are comparing two ways of delivering exercise therapy to people with multiple sclerosis: supervised sessions with a physiotherapist and a program followed over the internet. The study enrolls 34 adults with moderate to severe disability, measured by an EDSS score of 5…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a gut molecule shield nerve fibers in MS?
Symptom relief CompletedResearchers are testing whether propionic acid, a short-chain fatty acid, can slow nerve damage and ease fatigue in people with multiple sclerosis. The trial enrolls 101 adults aged 18 to 60 who have stable MS and signs of immune activity in their spinal fluid. Participants recei…
Phase 2/3 • Sponsor: Salzburger Landeskliniken • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New video program eases Parents' fear of Kids' low blood sugar
Symptom relief CompletedThis study tested a video-based telemedicine program called REDCHiP for parents of young children (ages 2-6) with type 1 diabetes. The program uses education, behavior training, and therapy to reduce parents' fear of hypoglycemia (low blood sugar). 396 families participated, comp…
Sponsor: Nemours Children's Clinic • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Could A2 milk ease gut symptoms in teens with celiac disease?
Symptom relief CompletedResearchers are testing whether milk and dairy products made with A2 beta-casein protein can improve gut symptoms, quality of life, sleep, and nutritional blood markers in adolescents with celiac disease. The trial enrolls 50 teens aged 10 to 18 who were diagnosed with celiac dis…
Sponsor: Halic University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can brain zaps boost social skills in kids with autism?
Symptom relief CompletedThis study tests whether 80 sessions of a gentle brain stimulation technique called tDCS, given over 12 months, can improve attention, social skills, and language in 180 children aged 6 to 11 who have autism along with rare diseases, genetic problems, or PANDAS. The treatment is …
Phase 1/2 • Sponsor: Spanish Foundation for Neurometrics Development • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can intense exercise help MS patients walk and think through fatigue?
Symptom relief CompletedFatigue is one of the most common problems in multiple sclerosis, and it can make walking, balance, and thinking harder. Researchers want to measure how fatigue changes these functions during a long walking test using wearable sensors. They are also testing whether a high-intensi…
Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can virtual forests help people with MS sleep better?
Symptom relief CompletedResearchers at Ataturk University are testing whether watching nature videos through virtual reality glasses can improve sleep quality and mental well-being in people with multiple sclerosis. The trial enrolls 42 adults aged 18 to 80 who have MS and are not in an attack. One grou…
Sponsor: Ataturk University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can pilates steady the steps of people with multiple sclerosis?
Symptom relief CompletedThis trial tests whether an 8-week Clinical Pilates program can improve balance and physical function in adults with multiple sclerosis. Participants are randomly assigned to Clinical Pilates, standard physiotherapy, or a control group with no structured exercise. Researchers mea…
Sponsor: University of Patras • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a Low-THC cannabis extract calm the sudden psychiatric storm of PANS?
Symptom relief CompletedResearchers are testing a full-spectrum medicinal cannabis extract called NTI164, which contains 0.08% THC, in children with pediatric acute-onset neuropsychiatric syndrome (PANS). PANS causes sudden, severe obsessive-compulsive symptoms, restricted eating, and other psychiatric …
Phase 1/2 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New robotic suit with electric zaps aims to restore walking after brain or spinal injury
Symptom relief CompletedThis study is testing a robotic lower-limb exoskeleton combined with functional electrical stimulation (FES) to help people with conditions like spinal cord injury, brain injury, or multiple sclerosis improve their walking. The device provides robotic support and electrical stimu…
Sponsor: ABLE Human Motion S.L. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can a mindfulness app ease the stress of hospitalization?
Symptom relief CompletedThis pilot study tests whether a mindfulness program delivered through a web app can help hospitalized neurological patients and their caregivers cope with stress and anxiety. Participants learn mindfulness techniques in an initial face-to-face session, then practice via weekly o…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can talk therapy plus exercise beat arthritis fatigue?
Symptom relief CompletedThis trial tests a new 24-week program called COMFI that combines a cognitive behavioral approach with physical activity to help people with inflammatory arthritis manage fatigue. Participants attend group sessions, an optional individual session, and a booster session, and they …
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
A softer path to stronger muscles for arthritis?
Symptom relief CompletedThis study tests whether blood flow restriction training (BFRT) — using pressure cuffs during low-load exercise — can help people with rheumatoid or psoriatic arthritis build muscle with less joint strain than conventional strength training. Adults with these conditions will be r…
Sponsor: University of Bonn • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Could music be medicine for the injured brain?
Symptom relief CompletedThis trial tests whether adding music therapy to standard rehabilitation helps people recover better after serious neurological injuries like stroke, brain injury, or spinal cord damage. About 75 participants aged 16-80 will be randomly assigned to receive either music therapy or…
Sponsor: University College, London • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could targeted exercises rebuild strength after Guillain-Barré?
Symptom relief CompletedThis trial tests whether combining proprioceptive neuromuscular facilitation (a type of stretching that improves flexibility and strength) with core strengthening exercises can help people with Guillain-Barré syndrome recover balance, muscle strength, and the ability to perform d…
Sponsor: Rida • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Dancing away arthritis: could tango boost daily activity?
Symptom relief CompletedThis study tests whether learning Argentine tango can increase overall physical activity in people with chronic inflammatory arthritis, such as rheumatoid arthritis or spondyloarthritis. Participants will take tango sessions that focus on body awareness, movement, and connection …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Dietary twist: Low-Histamine mediterranean plan shows promise for MS fatigue
Symptom relief CompletedThis study tested whether a low-histamine version of the Mediterranean diet could help people with relapsing-remitting multiple sclerosis (MS) feel better. 51 adults were split into three groups: one followed the low-histamine Mediterranean diet, another a standard Mediterranean …
Sponsor: Firat University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Could boxing in VR help MS patients get fit?
Symptom relief CompletedThis study tested whether a high-intensity virtual reality boxing program is safe and feasible for people with multiple sclerosis. Five participants used a VR headset to exercise for 10 minutes twice a week over 8 weeks, alongside their usual therapy. Researchers measured side ef…
Sponsor: University of Vigo • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Simple chin and neck exercises put to the test for MS swallowing problems
Symptom relief CompletedThis trial compares two exercise programs—chin tuck against resistance (CTAR) and proprioceptive neuromuscular facilitation (PNF) neck stretches—for people with multiple sclerosis who have trouble swallowing. Over 8 weeks, participants perform supervised sessions three times a we…
Sponsor: Sanko University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Brain boot camp: can a memory-training program sharpen thinking in multiple sclerosis?
Symptom relief CompletedThis trial tests whether a structured memory training program, called Strategy-Based Training to Enhance Memory (STEM), can improve learning and recall in people with multiple sclerosis who report memory difficulties. Participants attend eight training sessions over four weeks an…
Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Robot suit helps MS patients walk again – small study shows promise
Symptom relief CompletedThis study tested a robotic exoskeleton called Atalante to see if it is easy and safe for people with multiple sclerosis (MS) to use. 15 adults with MS who had trouble walking tried the device. The goal was to see if the suit could help them walk better and if they liked using it…
Sponsor: Multiple Sclerosis Center of Catalonia • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Robotic arm could help people with paralysis regain independence at home
Symptom relief CompletedThis study tests whether a wheelchair-mounted robotic arm called Jaco helps people with tetraplegia perform daily tasks like grasping and reaching at home. Participants use the device for two months after training. Researchers measure changes in performance and satisfaction with …
Sponsor: Association APPROCHE • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Nurse sessions may help arthritis patients handle biologic drugs safely
Symptom relief CompletedThis study tested whether nurse-led consultations can help people with rheumatoid arthritis become more independent in managing their subcutaneous biotherapy. Many patients struggle to recognize warning signs and delay seeking help. The study enrolled 71 adults with rheumatoid ar…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Snap a photo, count carbs: app aims to simplify type 1 diabetes meals
Symptom relief CompletedThis study tested a smartphone app called SNAQ that estimates the carbohydrate content of a meal from a single photo. The goal was to see if using the app helps people with type 1 diabetes keep their blood sugar in a healthy range. 44 adults who already use an automated insulin p…
Sponsor: Lia Bally • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Yogurt power: probiotics may ease fatigue in MS patients
Symptom relief CompletedThis study tested whether adding probiotics (found in yogurt and yeast tablets) to standard therapy could improve fatigue, quality of life, mood, and inflammation in 60 people with relapsing-remitting multiple sclerosis. Participants were randomly assigned to take probiotics or n…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a blood flow cuff help MS patients walk better?
Symptom relief CompletedThis study looked at whether 8 weeks of low-load leg exercises with a blood flow restriction cuff is safe and doable for people with multiple sclerosis who have moderate to severe walking problems. Sixteen adults with MS took part, doing exercises like knee extensions and hip lif…
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Ancient chinese practice tested to ease lupus fatigue and stress
Symptom relief CompletedThis study tested whether practicing Qi Gong, a gentle mind-body exercise, could improve quality of life in people with systemic lupus erythematosus (SLE). Thirty-three participants took part in weekly Qi Gong sessions for six months. Researchers measured changes in physical func…
Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Placebo power: fake TENS and kind words may ease MS fatigue
Symptom relief CompletedThis completed pilot study looked at whether a placebo treatment — sham TENS combined with positive verbal suggestions — could reduce fatigue in people with relapsing-remitting multiple sclerosis. 36 participants were enrolled. The main goal was to measure motor performance (numb…
Sponsor: Istituto Auxologico Italiano • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can mindfulness ease arthritis pain? small study seeks answers
Symptom relief CompletedThis completed pilot study tested an 8-week online mindfulness course in 38 people with rheumatoid arthritis. The goal was to see if patients liked the program, what barriers they faced, and how it might affect symptoms. Half the group took the course while the other half receive…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Robot suit could help MS patients walk again – small trial underway
Symptom relief CompletedThis study explores whether a powered exoskeleton—a wearable robot—can help people with moderate to severe walking problems due to multiple sclerosis (MS) exercise and walk better. Twenty-four participants will either use the exoskeleton or do standard exercises with a fitness in…
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Plasma swap shows promise for tough MS attacks
Symptom relief CompletedThis study tested whether plasma exchange (a blood-filtering treatment) helps people with multiple sclerosis who have severe flare-ups that don't get better with steroids. Thirty-eight adults took part, and researchers compared real plasma exchange to a sham procedure. The main g…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
MS fatigue study tests l-carnitine supplement
Symptom relief CompletedThis study tested whether L-carnitine, a natural supplement, can reduce fatigue in people with multiple sclerosis (MS). About 60 adults with MS who had significant fatigue took either L-carnitine or a placebo, then switched. The goal was to see if L-carnitine improved fatigue sco…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Robot suit helps GBS patients take steps again
Symptom relief CompletedThis study tested whether the Atalante X exoskeleton, a robotic leg brace, is safe and helpful for people with Guillain-Barré syndrome who cannot walk. Eleven participants used the device in 20 training sessions over six weeks. Researchers measured safety, ease of use, and any im…
Sponsor: Institut Guttmann • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Cancer drug repurposed to fight rare skin disease in small safety trial
Symptom relief CompletedThis early-phase study tested whether a drug used for lymphoma, brentuximab vedotin, is safe for people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis). The drug targets overactive immune cells that may drive the disease. Only 17 people took part, and the…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can an app beat fatigue in scleroderma? small study tests feasibility
Symptom relief CompletedThis study tested a smartphone app called RENEW designed to help people with scleroderma manage fatigue and build resilience. Over 12 weeks, 43 participants used the app to set and track weekly healthy goals. The main goal was to see if people would actually use the app and compl…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can acupressure ease MS symptoms? new study says maybe
Symptom relief CompletedThis study tested whether acupressure, a technique where pressure is applied to specific points on the body, can help people with multiple sclerosis (MS) manage pain, fatigue, and sleep problems. Researchers enrolled 90 adults with relapsing-remitting MS who had moderate to sever…
Sponsor: Hasan Kalyoncu University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New device AVELI tackles cellulite and fibrosis in liposuction patients
Symptom relief CompletedThis study tested a device called AVELI to safely reduce cellulite and fibrous tissue in 130 people undergoing body contouring surgery. Researchers measured safety, patient satisfaction, and appearance improvements over 9 months. The goal was to see if adding AVELI to standard li…
Sponsor: Total Definer Research Group • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Texting teens: a new way to ease the diabetes transition?
Symptom relief CompletedThis study tested whether personalized text messages could help young adults with type 1 diabetes feel more confident managing their condition as they moved from pediatric to adult care. 234 participants received either usual care or usual care plus a text messaging program. The …
Sponsor: The Hospital for Sick Children • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can a common Alzheimer's drug clear lupus brain fog?
Symptom relief CompletedThis study tested whether memantine, a drug used for Alzheimer's, can help with thinking and memory problems in people with lupus. About 111 adults with lupus and cognitive issues took either memantine or a placebo for 14 weeks. The goal was to see if the drug safely improves bra…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can nerve zaps give MS patients a better grip?
Symptom relief CompletedThis study tested two types of nerve stimulation—one using tiny needles (PENS) and one using skin pads (TENS)—to see if they could improve hand function in people with multiple sclerosis. 28 participants received a single session of stimulation, and their hand dexterity, strength…
Sponsor: Universidad de Burgos • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Dietary formula shows promise for psoriatic arthritis symptom relief
Symptom relief CompletedThis study tested whether a food formula containing medium-chain triglycerides (MCTs) and vegetable fibers could improve quality of life in 72 adults with psoriatic arthritis and low disease activity. Participants took the formula for 3 months while continuing their usual medicat…
Sponsor: Dr. Schär AG / SPA • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Chill out: cryotherapy tested for MS fatigue
Symptom relief CompletedThis study tested whether partial-body cryotherapy (standing in a very cold chamber for 2-3 minutes) could help reduce fatigue in people with multiple sclerosis during a rehabilitation stay. 43 participants received either real cryotherapy at -120°C or a sham version at -30°C ove…
Sponsor: Fondation Ildys • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Step by step: walking program shows promise for lupus fatigue
Symptom relief CompletedThis study tested whether a simple walking program using a pedometer could help reduce fatigue and improve quality of life in people with lupus. 101 participants were randomly assigned to either a walking group with personalized step goals or a wait-list control group. The progra…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can a smartphone app ease rheumatoid arthritis symptoms?
Symptom relief CompletedThis study tested a mobile app designed to help people with rheumatoid arthritis manage their condition. 90 adults with stable treatment used the app for 12 weeks, while a control group received usual care. Researchers measured changes in disease activity and quality of life to s…
Sponsor: Kırıkkale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Online program aims to reduce falls in MS patients
Symptom relief CompletedThis study tested a digital group program called 'Fewer Falls in MS' for people with multiple sclerosis who had fallen in the past year. 240 participants either joined the 8-session online program or received a brochure. Researchers tracked falls and other outcomes over 12 months…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a new oat variety be safe for celiac patients?
Symptom relief CompletedThis study tested whether a low-immunogenic oat variety called Saul is well-tolerated by adults with celiac disease who are in remission. Forty participants ate 50 grams of gluten-free Saul oat flakes daily for 14 days. Researchers tracked symptoms and blood markers to see if the…
Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Laser zaps face veins in scleroderma patients – 21 test it out
Symptom relief CompletedThis study tested a pulsed dye laser to reduce red veins (telangiectasias) on the face and neck in 21 people with scleroderma. Participants received four laser sessions, and the researchers checked how many veins disappeared, how patients felt about the results, and any side effe…
Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Cutting salt and sugar may tame steroid side effects
Symptom relief CompletedThis study looked at whether a diet low in salt and sugar can reduce common side effects of corticosteroid treatment, such as weight gain, high blood pressure, and diabetes. Fifty adults with autoimmune diseases or asthma who were starting high-dose corticosteroids were randomly …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can an antioxidant boost light therapy for vitiligo?
Symptom relief CompletedThis study tested whether adding a special antioxidant pill (GLISODIN) to standard UVB light therapy helps treat vitiligo better than light therapy alone. Fifty adults with non-segmental vitiligo covering more than 5% of their body took part. The main goal was to see if the combi…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Walking away from Sjögren's fatigue: study tests simple exercise
Symptom relief CompletedThis study looked at whether regular aerobic exercise, like walking, can reduce fatigue in women with primary Sjögren's syndrome. Forty-five women participated in a 16-week program. Researchers measured changes in fatigue, mood, and physical fitness.
Sponsor: Samira Tatiyama Miyamoto, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New study examines pain and adherence in patients switching to concentrated adalimumab
Symptom relief CompletedThis study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration form of adalimumab (AVT-02). Researchers measured injection site pain and how well patients stuck with their treatment over 180 days…
Sponsor: Jamp Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New online classes aim to ease MS muscle tightness
Symptom relief CompletedThis study tested two online programs designed to help people with multiple sclerosis manage spasticity (muscle tightness) in their legs. Participants attended two video classes that included education and stretching exercises. The goal was to see if these programs could reduce t…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Rehab program shows promise for scleroderma Patients' daily life
Symptom relief CompletedThis study tested whether a personalized rehabilitation program could improve quality of life for people with systemic sclerosis, a disease that causes skin and joint stiffness. 220 adults with the condition were randomly assigned to either the rehab program or usual care. The pr…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can your own blood soothe dry eyes? new study says maybe.
Symptom relief CompletedThis study tested whether eye drops made from a patient's own blood (autologous serum) can relieve severe dry eye better than standard artificial tears. 46 adults with severe dry eye tried both diluted (20%) and full-strength (100%) serum drops, as well as artificial tears. The m…
Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Mind and body combo boosts mobility in MS patients
Symptom relief CompletedThis study looked at whether adding cognitive behavior therapy (a type of talk therapy) to supervised Pilates exercises could improve balance, walking, and fatigue in people with multiple sclerosis. 90 adults with mild to moderate MS took part. The goal was to see if combining me…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Remote Check-Ins may ease psoriatic arthritis symptoms
Symptom relief CompletedThis study tested whether two structured telemedicine visits, added between regular doctor appointments, could help people with psoriatic arthritis improve their quality of life and reduce disease impact. 101 adults with active symptoms took part. The visits focused on lifestyle …
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
App + fitbit helps arthritis patients take control
Symptom relief CompletedThis study tested a program called OPERAS that includes a web app for tracking symptoms and a physiotherapist who gives activity advice using a Fitbit. The goal was to see if it helps people with rheumatoid arthritis feel more confident managing their disease. 132 adults with rhe…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Herbal remedy tested for lupus fatigue in small trial
Symptom relief CompletedThis study tested whether an herbal supplement could reduce fatigue in people with lupus. 59 adults with lupus and significant tiredness took either the supplement or a placebo for 8 weeks. The main goal was to see if fatigue and disease activity improved. The results may offer a…
Sponsor: University Tunis El Manar • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
At-Home brain zaps show promise for MS fatigue
Symptom relief CompletedThis study tested whether a safe, non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) could reduce fatigue in people with multiple sclerosis (MS). Ten adults with MS-related fatigue used a home-based tDCS device. The goal was to see if i…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Exercise at home may restore low blood sugar warning signs in type 1 diabetes
Symptom relief CompletedThis study tested whether adding a 12-week home-based high intensity interval training program to standard education about preventing low blood sugar (hypoglycemia) helps adults with type 1 diabetes who have lost the ability to sense low blood sugar. 47 participants were randomly…
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Chair yoga may ease scleroderma symptoms, small study hints
Symptom relief CompletedThis pilot study tested whether gentle yoga and breathing exercises are feasible for people with scleroderma, a condition that can limit movement. Thirty participants learned chair-based yoga and breathing techniques, then practiced twice daily at home for 10 weeks. Researchers m…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Can an elliptical trainer help MS patients walk better?
Symptom relief CompletedThis study looked at how aerobic exercise on an elliptical trainer or a treadmill affects walking, balance, and stability in people with moderate multiple sclerosis. Thirty adults with MS completed the exercise programs. The goal was to see which machine might improve gait and wa…
Sponsor: Soroka University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Timing your workout could tame blood sugar spikes in type 1 diabetes
Symptom relief CompletedThis study looked at whether exercising before or after lunch is better for controlling blood sugar in women with type 1 diabetes, including those who are pregnant. Twenty women participated, and researchers measured how much time their blood sugar stayed in a healthy range over …
Sponsor: University of Graz • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Lupus Self-Help program tested in african american women
Symptom relief CompletedThis study tested whether a 6-week self-management workshop, called the Chronic Disease Self-Management Program, could improve health and reduce healthcare use in African American women with lupus. Nearly 700 women from the GOAL study took part. The program covers topics like dea…
Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Exercise eases stiffness in ankylosing spondylitis patients
Symptom relief CompletedThis study tested whether a 9-week personalized physical training program using an exercise bike could help people with ankylosing spondylitis, a type of arthritis that affects the spine. Fifty-six patients participated, and researchers measured how many achieved a meaningful imp…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can a custom diet help MS patients strengthen bones?
Symptom relief CompletedThis study tested whether personalized dietary advice from a dietitian helps people with multiple sclerosis (MS) get more calcium in their diet. 182 MS patients who could still walk were split into two groups: one received one-on-one dietitian sessions, the other got a standard a…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New eye drops aim to soothe Sjogren's dry eye sufferers
Symptom relief CompletedThis Phase 3 study tested cenegermin (Oxervate) eye drops against a placebo in 85 adults with severe dry eye caused by Sjogren's syndrome, who were already using cyclosporine drops. The goal was to see if cenegermin could increase tear production and reduce eye discomfort over 4 …
Phase 3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Tape it better? small study tests kinesiologic taping for knee arthritis pain
Symptom relief CompletedThis completed trial tested whether kinesiologic taping (a special elastic tape) applied to the knee can reduce pain, improve mobility, and lessen fear of movement in people with rheumatoid arthritis. Thirty adults aged 45 to 60 were randomly assigned to receive either real kines…
Sponsor: Istanbul Rumeli University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can blood markers predict how MS affects walking and thinking?
Knowledge-focused CompletedResearchers are studying whether certain immune substances in the blood are linked to physical and mental abilities in people with relapsing-remitting multiple sclerosis. The study includes 20 adults aged 19 to 45 with mild disability. Participants give blood samples, and researc…
Sponsor: Halic University • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Iron nanoparticle could light up MS brain inflammation on MRI
Knowledge-focused CompletedThis early-phase study tested whether ferumoxytol, an iron-based contrast agent, can help MRI scans better detect inflammation in the brains of people with multiple sclerosis (MS). Fourteen participants (some with MS, some healthy) received a single IV dose of ferumoxytol and had…
Phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused CompletedThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Period power: study reveals how hormones impact blood sugar control
Knowledge-focused CompletedThis study looks at how the menstrual cycle changes blood sugar and energy use in women with type 1 diabetes. About 40 women will use a closed-loop insulin pump and continuous glucose monitor to track these changes. The goal is to understand how hormone shifts affect insulin need…
Sponsor: Lia Bally • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a blood marker reveal how rehabilitation affects axial spondyloarthritis?
Knowledge-focused CompletedResearchers at Giresun University are studying whether a blood protein called calprotectin changes in people with axial spondyloarthritis who complete a four-week pulmonary rehabilitation program. Thirty patients aged 25 to 65 will take part. The team will measure calprotectin al…
Sponsor: Giresun University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare inflammatory diseases
Knowledge-focused CompletedThis study follows up to 5,000 people with autoinflammatory diseases (like NOMID, CANDLE, and juvenile dermatomyositis) and their healthy relatives. Researchers will collect medical history, blood samples, and imaging over 2-5 day visits to learn how these diseases work and find …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Gut bacteria eyed as hidden trigger in autoimmune clotting disorder
Knowledge-focused CompletedResearchers at Yale University are studying whether certain gut bacteria are linked to the autoantibodies that drive antiphospholipid syndrome, an autoimmune disorder that causes dangerous blood clots. The study follows 16 adults, including patients with the syndrome, people who …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists hunt for hidden triggers of autoimmune diseases
Knowledge-focused CompletedThis study collects tissue and blood samples from 300 people with autoimmune diseases like Crohn's, multiple sclerosis, and celiac disease. Researchers aim to identify the specific targets of immune cells (T cells) that cause inflammation. The goal is to discover new targets for …
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scleroderma patients to decide: infographic vs. plain language for research results
Knowledge-focused CompletedThis study aims to find the best way to share research results with people who have scleroderma, a rare autoimmune disease. About 128 participants will be randomly assigned to receive either an infographic or a plain-language summary of a study. They will then rate how complete, …
Sponsor: Lady Davis Institute • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study aims to unlock diabetes mysteries in kazakh adults
Knowledge-focused CompletedThis completed study in Kazakhstan looked at 240 adults recently diagnosed with diabetes. Researchers measured blood sugar, insulin resistance, and immune markers to understand how different forms of diabetes develop. The goal is to help doctors diagnose and treat adult-onset dia…
Sponsor: West Kazakhstan Marat Ospanov Medical University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Could poor balance be the hidden link between MS fatigue and fear of falling?
Knowledge-focused CompletedThis study investigates whether balance problems explain why fatigue leads to a greater fear of falling in people with multiple sclerosis (MS). Researchers will assess fatigue, balance, and fear of falling in 40 adults with MS who can walk independently or with a device. The goal…
Sponsor: Uskudar University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Twin study seeks clues to rheumatic disease mysteries
Knowledge-focused CompletedThis study looks at families where one sibling has a rheumatic disease (like rheumatoid arthritis or lupus) and the other does not. Researchers compare their blood, genes, and environmental exposures to find clues about why one got sick. Over 1,000 participants are involved, incl…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can a Nurse's coaching get MS patients to speak up about drug side effects?
Knowledge-focused CompletedPeople with multiple sclerosis often do not report side effects from their oral disease-modifying drugs, which leaves safety monitoring incomplete. This trial compares two ways of encouraging reports: a nurse who trains the patient and follows up by phone over six months, versus …
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can a simple step test spot balance issues in arthritis patients?
Knowledge-focused CompletedThis study checks whether the Four Square Step Test (FSST) is a good way to measure balance in people with rheumatoid arthritis. Researchers will test 50 adults aged 18-65 with RA, comparing FSST results to other measures like disease activity, pain, and muscle strength. The goal…
Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Study reveals bone risks from common skin treatment
Knowledge-focused CompletedThis study looked at 47 people with bullous pemphigoid, a blistering skin condition, who were treated with high-dose topical corticosteroids (clobetasol propionate) for 6 months. Researchers measured bone mineral density at the start, at 3 months, and at 6 months to see if the tr…
Phase 4 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Real-World data may reveal which ITP treatments work best
Knowledge-focused CompletedThis study looks back at health records from over 3,700 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys blood platelets, raising bleeding risk. Researchers want to see which second-line treatments doctors prescribe after first-line steroids…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Skin markers may reveal how light therapy fights vitiligo
Knowledge-focused CompletedThis study looks at whether a common light treatment for vitiligo changes certain proteins in the skin. Researchers will measure two markers, CD63 and CD9, in skin samples from 20 people with vitiligo before and after three months of narrow-band ultraviolet B (NB-UVB) therapy. Th…
Sponsor: Amany El-Agamy Ibrahim El-Samadony • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can fear of movement worsen fatigue in MS?
Knowledge-focused CompletedThis study investigates whether people with multiple sclerosis experience kinesiophobia, a fear of movement, and how it relates to fatigue. Researchers will assess 352 adults with MS using scales for disability, spasticity, walking speed, pain, sleep, anxiety, and depression. The…
Sponsor: Dokuz Eylul University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can these supplements boost nutrient absorption in chronic illness?
Knowledge-focused CompletedThis study is testing whether two dietary supplements, Goodphyte IB Defense and Goodphyte Immunity, are acceptable and easy for adults with chronic diseases like IBD, hypertension, anemia, or multiple sclerosis to take. Researchers will also check if the supplements improve how w…
Sponsor: University of Thessaly • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists hunt for genetic and environmental triggers of rare muscle diseases
Knowledge-focused CompletedThis study looked at 719 people, including patients with autoimmune connective tissue diseases like myositis, their blood relatives, and healthy volunteers. Researchers collected blood samples and medical histories to find genetic and environmental factors that may trigger these …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Farming exposures under the microscope: massive health study follows 90,000 participants
Knowledge-focused CompletedThis study follows nearly 90,000 farmers and their spouses to track long-term health effects of pesticides, crops, and animals. Participants report new medical conditions, which researchers then confirm through medical records and genetic samples. The goal is to better understand…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a T-Cell signature unlock the secrets of autoimmune liver disease?
Knowledge-focused CompletedThis study aims to identify the unique molecular signature of immune cells called T cells that mistakenly attack the liver in autoimmune liver diseases like autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. Researchers will analyze blood sampl…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists hunt for allergy genes in massive screening study
Knowledge-focused CompletedThis study screened up to 1,000 people with severe allergic conditions—like anaphylaxis, eczema, and asthma—along with their relatives to find genetic causes. Researchers collected blood samples and medical history to link specific gene mutations to these diseases. No treatment w…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New program aims to improve pregnancy care for women with lupus
Knowledge-focused CompletedThis study tests a program called HOP-STEP that helps doctors talk about pregnancy planning with women who have lupus. The goal is to make sure doctors document contraception use and pregnancy intentions during visits. The study involves 14 participants and is being tested at two…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can reading emotions explain social struggles in MS?
Knowledge-focused CompletedResearchers are asking whether people with multiple sclerosis who have trouble reading emotions also face more difficulties in family life, friendships, and social integration. The study compares three groups: MS patients with emotional processing problems, MS patients without su…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Are women with autoimmune diseases getting the gynecological care they need?
Knowledge-focused CompletedThis study examined whether women with autoimmune diseases or inflammatory rheumatism receive proper gynecological follow-up, including cervical cancer screening and contraception advice. Researchers surveyed 318 women with conditions like lupus, rheumatoid arthritis, and Sjögren…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
A blood test that could predict clots in autoimmune disease?
Knowledge-focused CompletedThis study looks at whether two additional lab tests can better predict the risk of blood clots in people with antiphospholipid syndrome (APS), an autoimmune condition that can cause clots and pregnancy complications. Researchers will measure specific antibodies and thrombin gene…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Could a stress hormone be behind the hidden danger of low blood sugar?
Knowledge-focused CompletedThis study looks at whether adrenaline, the body's stress hormone, triggers an immune reaction during low blood sugar (hypoglycemia) in people with and without type 1 diabetes. Researchers will lower participants' blood sugar and then give drugs that block adrenaline's effects to…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Hidden thyroid cancers: how common are they in patients with thyroiditis?
Knowledge-focused CompletedThis completed study from Minia University looked at 200 patients with autoimmune thyroiditis (an inflamed thyroid) who had thyroid surgery. The goal was to see how often thyroid cancer is found by accident when examining the removed tissue. Researchers checked for cancer in pati…
Sponsor: Minia University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can group learning make biotherapy safer for arthritis patients?
Knowledge-focused CompletedThis trial investigates whether combining group and individual educational sessions helps patients with chronic inflammatory rheumatism (like rheumatoid arthritis or spondyloarthritis) learn safety skills better than individual sessions alone. Participants are starting their firs…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Gluten: friend or foe for elite athletes?
Knowledge-focused CompletedThis trial investigates whether gluten consumption affects digestive comfort, quality of life, and physical performance in non-celiac athletes who train intensively. Participants, who are healthy and free of digestive diseases, will be randomly assigned to a gluten-containing or …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can MS treatments protect the mind as well as the body?
Knowledge-focused CompletedThis study follows people with relapsing-remitting multiple sclerosis who are starting immunosuppressant treatment. Researchers will track changes in cognitive abilities, fatigue, emotions, and overall quality of life over an extended period. The goal is to better understand how …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New study tracks brain decline in progressive MS
Knowledge-focused CompletedThis study follows 66 people with primary progressive multiple sclerosis (PPMS) and healthy volunteers for two years to understand how thinking and memory change over time. Participants take cognitive tests and undergo MRI scans to see how brain tissue damage relates to mental de…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Blood test may spot hidden nerve damage behind chronic constipation
Knowledge-focused CompletedThis study investigates whether a blood test can identify nerve damage in the bowel wall that may cause chronic constipation and defecation disorders. Researchers will compare blood samples and tissue from 100 adults undergoing surgery for obstructive defecation disorder to see i…
Sponsor: Evangelisches Klinikum Köln Weyertal gGmbH • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Smartphone videos could replace the doctor's joint exam for arthritis?
Knowledge-focused CompletedThis study tests whether a smartphone-based digital assessment can measure rheumatoid arthritis activity as well as a standard doctor-performed exam. Adults with rheumatoid arthritis will complete a digital questionnaire, record guided videos of their joint movements, and then ha…
Sponsor: Synovo Ltd. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can type 1 diabetes hold kids back from being fit and active? a study aims to find out.
Knowledge-focused CompletedThis study looks at how type 1 diabetes affects the heart, lungs, and overall fitness of children aged 6 to 17. It also measures their physical activity levels and quality of life. Researchers will compare these results with those of healthy children of the same age. The goal is …
Sponsor: Institut Saint Pierre • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Menstrual cycle forces women with diabetes to hack their insulin pumps
Knowledge-focused CompletedThis study investigates how women with type 1 diabetes manually adjust their automated insulin delivery (AID) systems to manage blood sugar changes during their menstrual cycle. Researchers will interview 69 women to catalog strategies like entering fake carbohydrates or changing…
Sponsor: DCB Research AG • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Large UK study tracks COVID-19's toll on MS patients
Knowledge-focused CompletedThis study follows thousands of people with multiple sclerosis (MS) in the UK to see how COVID-19 affects them. Researchers track infections, hospital stays, and deaths using questionnaires and national health data. The goal is to understand the risks and outcomes for this group,…
Sponsor: Swansea University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Scientists hunt for genetic roots of rare childhood blood disorder
Knowledge-focused CompletedThis study investigates the genetic causes of pediatric Evans syndrome, a rare autoimmune condition where the immune system attacks blood cells. Researchers analyze blood samples from affected children and their families to find known or new mutations. The goal is to better under…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Race day blood sugar spike: study probes stress effect on athletes with type 1 diabetes
Knowledge-focused CompletedThis study investigates why athletes with type 1 diabetes often experience higher blood sugar during competitions compared to regular training. Researchers will monitor 12 athletes with type 1 diabetes and 12 healthy athletes during a 5K race and a 5K training session, measuring …
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Walking and thinking at the same time may reveal hidden MS balance issues
Knowledge-focused CompletedThis study looked at whether asking people with multiple sclerosis (MS) to do two things at once — like walking while thinking — can uncover balance problems that standard tests miss. Researchers studied 24 people with mild MS and low disability. The goal was to see if this dual-…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Tiny study aims to predict lupus flares before they strike
Knowledge-focused CompletedThis completed study enrolled 6 adults with systemic lupus erythematosus (SLE) to collect blood, urine, saliva, stool, and tissue samples over time. The goal was to find biological markers that could predict when a patient's disease might flare up or how they might respond to tre…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Sjögren's muscle mystery: study aims to classify inflammatory involvement
Knowledge-focused CompletedThis study looked at 54 people with primary Sjögren's syndrome who also had muscle inflammation. Researchers wanted to see how many met the official criteria for inflammatory myopathies. The goal was to better understand and classify muscle disease in Sjögren's patients.
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New study aims to measure fear of hypoglycemia in french kids with diabetes
Knowledge-focused CompletedThis study tests French versions of three questionnaires that measure fear of low blood sugar (hypoglycemia) in children with type 1 diabetes and their parents. The goal is to ensure these tools are reliable for French-speaking families. About 194 children aged 2 to 18 and their …
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Tilt and pressure test reveals heart secrets in diabetes
Knowledge-focused CompletedThis study looked at how the heart fills and pumps blood when the body is tilted or exposed to lower body pressure. Researchers compared 30 people with type 1 diabetes and healthy volunteers. They used heart monitoring and ultrasound to measure changes, aiming to understand how d…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Carbs and kids: new study reveals how diet impacts diabetes control with smart pumps
Knowledge-focused CompletedThis study looked at 347 children and teens with type 1 diabetes who use the Medtronic MiniMed 780G insulin pump. Researchers tracked how much carbohydrate they ate each day and measured their blood sugar control over time. The goal was to understand the link between daily carb i…
Sponsor: University of Ljubljana, Faculty of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes
Knowledge-focused CompletedThis study follows people newly diagnosed with psoriatic arthritis (PsA) to see how a 'treat to target' approach works in everyday clinics. Participants receive standard care, often starting with methotrexate, and their disease activity is tracked over time. The goal is to unders…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to unlock the secrets of Children's rare blood diseases
Knowledge-focused CompletedThis study follows children in France diagnosed with severe autoimmune cytopenia—conditions where the immune system attacks blood cells. Researchers will track their health over time to see who achieves remission and what factors influence their recovery. The goal is to better un…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple blood test predict who will get chronic ITP?
Knowledge-focused CompletedThis completed study looked at blood samples from 70 children and adults newly diagnosed with immune thrombocytopenic purpura (ITP), a condition that causes easy bruising and bleeding. Researchers wanted to see if certain immune and blood markers could predict whether the disease…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Stress hormone link to depression in diabetic children under the microscope
Knowledge-focused CompletedThis study investigates whether stress hormone activity is linked to depression and brain changes in children with type 1 diabetes. Researchers will measure cortisol levels and use brain scans in children aged 6–12 who have had diabetes for at least a year, comparing them to thei…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Study pits two MG drugs Head-to-Head in everyday practice
Knowledge-focused CompletedThis study looked at how well two drugs, azathioprine and mycophenolate mofetil, work for people with myasthenia gravis in everyday medical practice. Researchers followed 82 adults with autoimmune MG for 2-3 years, measuring quality of life and side effects. The goal was to provi…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe hidden memory system that might survive brain damage
Knowledge-focused CompletedThis completed study looked at how people learn and remember associations, like names or where you met someone. Researchers compared healthy young and older adults with patients who have memory problems from Alzheimer's or semantic dementia. They used memory tests and brain scans…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Immune cell study could pave way for new arthritis treatments
Knowledge-focused CompletedThis study looked at a type of immune cell called B regulatory cells in 100 people—some healthy and some with rheumatoid arthritis (RA). The goal was to understand how these cells differ between the two groups and how they might help control the disease. By identifying unique fea…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Spinal lesions in early MS may signal future mobility trouble
Knowledge-focused CompletedThis study followed 115 people with relapsing-remitting multiple sclerosis for up to 5 years to see if early damage to the spinal cord could predict later walking difficulties. Researchers used MRI scans and walking tests to track changes. The goal was to better understand how ea…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can text messages help arthritis patients take their meds?
Knowledge-focused CompletedThis study looked at three ways to help people with rheumatoid arthritis take their methotrexate medication as prescribed: usual doctor visits, text message reminders, or a chat with a pharmacist. The goal was to see which method works best to improve adherence. The study include…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could low vitamin c explain lingering pain in rheumatism and lupus?
Knowledge-focused CompletedThis study looks at whether people with chronic inflammatory rheumatism (like spondyloarthritis) or lupus who still have pain despite treatment have low vitamin C levels. Researchers will measure vitamin C in the blood and ask about pain, fatigue, and quality of life. The goal is…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Lung clues could unlock early rheumatoid arthritis detection
Knowledge-focused CompletedThis completed study looked at 340 people to understand how certain proteins in the lungs, called autoantibodies, might be linked to the start of rheumatoid arthritis (RA). Researchers collected sputum (mucus from the lungs) from people at risk for RA, those already diagnosed, an…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New arthritis drug copy tested in healthy people
Knowledge-focused CompletedThis study tested whether a new version of the arthritis drug abatacept (called KSHB002) works similarly to the approved drug Orencia. Three hundred healthy adults received a single injection of either the new drug or Orencia. Researchers measured drug levels in the blood, checke…
Phase 1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Blood samples shed light on mysterious muscle disease
Knowledge-focused CompletedThis completed study enrolled 311 people with myasthenia gravis, a condition that causes muscle weakness. Researchers collected clinical information and blood samples to build a repository for future studies. The goal is to help scientists better understand the disease and potent…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scleroderma Patients' nutrition under the microscope
Knowledge-focused CompletedThis study followed 150 adults with systemic sclerosis (scleroderma) for two years to track their nutritional health. Researchers measured weight, diet, and disease severity every six months. If malnutrition was found, patients received dietary advice or supplements. The goal was…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Wearable sensors could revolutionize how we track ankylosing spondylitis
Knowledge-focused CompletedThis study tested whether wearable motion sensors can accurately measure spinal movement in people with ankylosing spondylitis (AS), a condition that causes back pain and stiffness. Forty participants (20 with AS and 20 healthy volunteers) wore sensors while performing everyday m…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Rheumatism Patients' COVID antibodies under the microscope
Knowledge-focused CompletedThis study followed 163 people with chronic inflammatory rheumatism (like rheumatoid arthritis) who had a recent COVID-19 infection. Researchers measured their antibody levels over two years to see how immunosuppressive drugs affect antibody persistence. The goal was to better un…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Study reveals how well saudi doctors follow safety rules for common arthritis drug
Knowledge-focused CompletedThis study looked at whether healthcare professionals in Saudi Arabia are aware of and follow safety measures for the drug leflunomide, used for rheumatoid and psoriatic arthritis. Researchers surveyed 302 doctors and pharmacists to see if they received and read safety materials,…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
MS patients and caregivers share their care experiences in new study
Knowledge-focused CompletedThis study looked at how people with multiple sclerosis and their natural caregivers (like family members) feel about the quality of care they receive. Researchers surveyed over 1,000 participants to understand their expectations and experiences. The goal was to create a tool tha…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Pandemic stress hits hard for arthritis patients
Knowledge-focused CompletedThis completed study looked at how the COVID-19 pandemic and social distancing impacted the mental health of 259 adults with chronic inflammatory rheumatism (like rheumatoid arthritis or ankylosing spondylitis). Researchers used questionnaires to measure stress, depression, anxie…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New brain scans may reveal why nerves die in MS
Knowledge-focused CompletedThis study used advanced MRI scans to look at energy use in the brains of 40 people with multiple sclerosis and 15 healthy volunteers. The goal was to see if energy problems in brain cells can predict nerve damage over two years. Researchers hope this will help understand how MS …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Silent brain clues: new study hunts for early warning signs of multiple sclerosis
Knowledge-focused CompletedThis study looked at 320 people whose brain scans showed signs that sometimes lead to multiple sclerosis (MS), even though they had no symptoms. Researchers analyzed blood and spinal fluid samples to find biological markers that could predict whether these silent signs would turn…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Real-World study tracks why MS patients switch to kesimpta
Knowledge-focused CompletedThis study followed 307 people with relapsing multiple sclerosis in Germany who had recently switched to the drug Kesimpta (ofatumumab) from another treatment. Researchers collected information on why patients made the switch and how many doses they missed over one year. The goal…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New ultrasound technique may catch diabetic heart damage early
Knowledge-focused CompletedThis study tested whether a special heart ultrasound (speckle tracking strain echocardiography) can detect early heart muscle changes in 61 adults with type 1 diabetes, before symptoms appear. Researchers looked for links between these changes and small blood vessel damage (micro…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heat wave warning: study reveals how chronic illness patients suffer in high temperatures
Knowledge-focused CompletedThis completed study looked at how rising temperatures affect people with chronic conditions like heart disease, diabetes, and depression. Researchers in Germany and Italy surveyed 176 patients to see what symptoms they experienced during heat and what protective steps they took.…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Blood markers may predict arthritis drug success
Knowledge-focused CompletedThis study aimed to find blood markers that can predict whether the drug adalimumab will successfully treat ankylosing spondylitis after 6 months. Researchers analyzed blood samples from 50 adults starting adalimumab for the first time. The goal was to create an algorithm to help…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Massive study reveals COVID-19 risks for autoimmune patients
Knowledge-focused CompletedThis study looked at over 13,000 people with chronic inflammatory rheumatism or autoimmune diseases who had or were suspected to have COVID-19. Researchers tracked how many developed severe COVID-19 requiring intensive care or leading to death. They also examined risk factors lik…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Lockdown life: did staying home help young diabetics manage blood sugar?
Knowledge-focused CompletedThis study looked at how the COVID-19 lockdown changed blood sugar control and self-care in 77 young people aged 13 to 25 with type 1 diabetes. Researchers used data from a glucose monitoring platform to compare blood sugar levels before, during, and after the two-month lockdown …
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can an artificial pancreas help the Hardest-to-Control diabetes?
Knowledge-focused CompletedThis study looked at whether people with severe, long-term uncontrolled type 1 diabetes would accept and benefit from a closed-loop insulin delivery system (an 'artificial pancreas'). Researchers followed 66 adults with very high blood sugar levels over several years. The goal wa…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New biosensor aims to improve glucose control for type 1 diabetes patients
Knowledge-focused CompletedThis completed study tested a new biosensor designed to measure blood glucose every 10 minutes in people with type 1 diabetes who use an insulin pump. The sensor uses microdialysis to sample interstitial fluid and was compared to standard continuous glucose monitors (CGM) during …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Virtual reality could help spot thinking problems in MS patients
Knowledge-focused CompletedThis completed study looked at 75 people with relapsing-remitting multiple sclerosis (RRMS) who were taking the medication Aubagio. The goal was to see if virtual reality tests and real-world tasks could better detect cognitive (thinking) problems in everyday life compared to sta…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Gut clues could unlock Sjogren's mystery
Knowledge-focused CompletedThis study looked at whether immune cells from the intestine play a role in Sjogren's syndrome, an autoimmune disease that causes dry eyes and mouth. Researchers examined saliva gland samples from 57 adults suspected of having Sjogren's. The goal was to better understand the dise…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Islet transplants after kidney: a game changer for type 1 diabetes?
Knowledge-focused CompletedThis study looked at whether getting an islet transplant after a kidney transplant helps people with type 1 diabetes avoid kidney failure or death. Researchers reviewed data from 327 people in France who had a kidney transplant between 2000 and 2017. They compared those who also …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Tiny particles may hold clues to autoimmune diseases
Knowledge-focused CompletedThis study looked at tiny particles called microparticles in the blood and urine of people with lupus or scleroderma. Researchers wanted to see if these particles could help explain how these diseases work and possibly lead to better diagnosis or treatment. Over 200 adults partic…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Diabetes study reveals hidden impact on exercise performance
Knowledge-focused CompletedThis study looked at how type 1 diabetes and long-term blood sugar control (HbA1c) affect the body's ability to deliver and use oxygen during exercise. Researchers compared 79 people with and without diabetes to understand why fitness levels may be lower in those with high blood …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New computer test could spot MS brain fog faster
Knowledge-focused CompletedThis study tested a short, computerized cognitive assessment in 421 French-speaking adults with multiple sclerosis and healthy controls. The goal was to see if a brief battery of computer tests can reliably detect early cognitive issues, like slowed thinking and memory problems, …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
MS nerve damage unmasked: eye scans reveal hidden loss
Knowledge-focused CompletedThis study looked at how nerve cells in the eye are lost in people with multiple sclerosis (MS) even when there is no active inflammation. Researchers followed 64 adults with relapsing-remitting MS who were already part of a larger study. By using special eye scans over time, the…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Lupus clue: can a heart drug reveal hidden disease markers?
Knowledge-focused CompletedThis small pilot study looked at whether clopidogrel, a drug that stops blood clots, could lower a substance called sCD40L in people with lupus. Lupus is an autoimmune disease where the body attacks itself. The study involved 18 adults with lupus and measured sCD40L levels in the…
Phase 1/2 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Brain scans reveal hidden social struggles in MS patients
Knowledge-focused CompletedThis study used brain scans to understand why some people with multiple sclerosis have trouble with social thinking, like reading emotions or intentions. Researchers compared 35 MS patients to healthy volunteers using MRI while they performed social tasks. The goal was to see whi…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Scientists probe Immune-Vessel link in rare scleroderma
Knowledge-focused CompletedThis study looked at how blood vessel cells and immune cells talk to each other in people with systemic sclerosis, a rare autoimmune disease that causes skin hardening and organ damage. Researchers collected blood samples and skin biopsies from 350 participants to measure a speci…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Could your diet trigger lupus? new study investigates
Knowledge-focused CompletedThis study measured phytoestrogens (plant-based compounds) in the blood and urine of 63 premenopausal women with active lupus, other autoimmune diseases, or no disease. Researchers also asked about diet and measured estradiol levels. The goal was to see if these dietary compounds…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Lupus skin study reveals why patients skip meds
Knowledge-focused CompletedThis study looked at 202 adults with cutaneous lupus to see how well they follow their treatment plans and how satisfied they are with their care. Researchers used questionnaires to measure adherence, beliefs about medicine, anxiety, depression, and quality of life. The goal is t…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can a simple blood test help rheumatoid arthritis patients get the right drug?
Knowledge-focused CompletedThis study looked at whether measuring drug levels and anti-drug antibodies in the blood of rheumatoid arthritis patients can help doctors make better treatment decisions. 52 patients starting adalimumab or certolizumab were randomly assigned to have their test results shared wit…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists investigate immune cell role in rare IgG4 disease
Knowledge-focused CompletedThis study looked at a rare disease called IgG4-related disease, which causes swelling and scarring in organs. Researchers compared immune cells in the blood of 75 people: those with the disease, those with Sjogren syndrome, and healthy volunteers. The goal was to better understa…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Blood sample study explores new target for inflammatory arthritis
Knowledge-focused CompletedThis study looked at blood samples from 24 people with axial spondyloarthritis (a type of inflammatory arthritis) and 12 healthy volunteers to understand how a receptor called KIR3DL2 contributes to inflammation. Researchers also tested whether a drug called IPH4102 could reduce …
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Scientists investigate immune cells in multiple sclerosis
Knowledge-focused CompletedThis study examined a type of immune cell called 4BL B cells in people with multiple sclerosis (MS) and compared them to healthy controls. Researchers wanted to see if these cells are more common in MS and might contribute to inflammation. The study involved 125 participants and …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Study reveals hidden toll of skin changes in rare disease
Knowledge-focused CompletedThis study looked at how skin changes from systemic sclerosis affect a person's feelings about their appearance. Researchers compared 170 patients with the disease to healthy people using surveys about body image and emotional distress. The goal was to understand the burden of th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
ER alerts may help tame type 2 diabetes
Knowledge-focused CompletedThis completed trial tested whether electronic alerts in the emergency room can improve care for people with type 2 diabetes. The alerts prompted doctors to order an A1c test when blood sugar was very high, and to consider admitting the patient for better diabetes management. Res…
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Could blocking GLP-1 restore the Body's natural defense against low blood sugar?
Knowledge-focused CompletedThis completed study looked at why people with type 1 diabetes lose their natural defense against low blood sugar—the hormone glucagon. Researchers tested whether blocking a hormone called GLP-1 with a drug (exendin(9-39)amide) could restore glucagon release during low blood suga…
Sponsor: Asger Lund, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Eye camera spots hidden inflammation in MS patients
Knowledge-focused CompletedThis study used a special eye camera (adaptive optics) to look at blood vessel inflammation in the retina of 50 people with multiple sclerosis (MS) and healthy volunteers. The goal was to see if this inflammation differs between MS types and could serve as an early marker of dise…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can being 'In the Zone' help newly diagnosed MS patients?
Knowledge-focused CompletedThis completed study looked at 361 people recently diagnosed with multiple sclerosis to see if experiencing 'flow' (being fully absorbed in an activity) and mindfulness are linked to better mental health. Participants filled out online questionnaires about their mental health, an…
Sponsor: Marta Bassi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tiny study probes Tofacitinib's hidden effects on body composition
Knowledge-focused CompletedThis completed study looked at how tofacitinib, a rheumatoid arthritis drug, changes body fat, muscle, and bone density in 10 patients. Researchers measured visceral fat, lean mass, and bone marrow fat before and after treatment. The goal was to gather early data, not to prove th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Nurse detectives: early warning system for arthritis flares?
Knowledge-focused CompletedThis study looked at whether regular nurse check-ins could spot the return of rheumatoid arthritis symptoms sooner than standard doctor visits. 51 adults with controlled arthritis on rituximab took part. The goal was to see if nurses could detect early signs of a flare, potential…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Hidden danger: eating disorders worsen blood sugar in type 1 diabetes
Knowledge-focused CompletedThis study looked at how eating disorders, like anorexia or bulimia, impact blood sugar levels in women with type 1 diabetes. Researchers compared glucose control between those with and without eating disorders. The goal was to better understand these risks and improve screening …
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Cuddle cure: skin contact after C-Section boosts breastfeeding and calms nerves
Knowledge-focused CompletedThis study tested whether holding a newborn skin-to-skin right after a C-section (within 5 minutes) or within the first hour helps with breastfeeding, reduces anxiety, and keeps mom and baby healthy. 92 mothers and their newborns took part. The results showed that early contact c…
Sponsor: Çankırı Karatekin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Lupus Patients' Pill-Taking habits under the microscope
Knowledge-focused CompletedThis study looked at how often people with active lupus take their medication as prescribed. Researchers measured blood levels of hydroxychloroquine in 307 patients to find out who was skipping doses. The goal was to understand how common non-adherence is, especially in those wit…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Rituximab infection risk under the microscope
Knowledge-focused CompletedThis completed study followed 73 people with autoimmune diseases like rheumatoid arthritis or multiple sclerosis who were starting treatment with rituximab. The goal was to track how many developed serious infections and to understand what factors increase that risk. Researchers …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Hidden gut troubles in Sjögren's patients revealed
Knowledge-focused CompletedThis study looked at how often people with primary Sjögren's syndrome have digestive issues. Researchers asked 151 patients about 10 different digestive symptoms using a simple questionnaire. The goal was to understand which symptoms are most common and how they relate to how lon…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Scleroderma hand study reveals key differences in disability
Knowledge-focused CompletedThis study looked at 30 adults with scleroderma, an autoimmune disease that often causes hand stiffness and disability. Researchers measured how much movement was limited in each hand to compare the dominant and non-dominant sides. The goal was to better understand hand function …
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
AI coach for diabetes: small study tests personalized insulin advice
Knowledge-focused CompletedThis study tested a smartphone-based tool called PEPPER that gives personalized insulin dose advice to people with type 1 diabetes. The tool uses artificial intelligence to learn from each person's past data and includes safety features like low-glucose alarms. Eight adults used …
Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
How many autoimmune patients try alternative therapies? new study counts
Knowledge-focused CompletedThis completed study surveyed 121 adults with autoimmune diseases like lupus, Sjögren's syndrome, or scleroderma. Participants filled out a questionnaire about their use of alternative medicines. The goal was to find out how common these practices are in this patient group.
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Researchers aim to create a universal checklist for scleroderma
Knowledge-focused CompletedThis study aimed to create a standard set of items, called an ICF core set, to describe the health and functioning of people with systemic sclerosis (scleroderma). Researchers gathered input from 100 patients and experts to identify the most important aspects of the disease. The …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
MS and menstrual cycles: new study tracks exercise satisfaction
Knowledge-focused CompletedThis completed study looked at how women with multiple sclerosis (MS) respond to high-intensity interval training and strength training at different points in their menstrual cycle. Fifteen women with MS and 15 without MS took part in exercise sessions and reported their satisfac…
Sponsor: Universidad de Almeria • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Which automated insulin pump keeps blood sugar tightest? study pits top systems Head-to-Head
Knowledge-focused CompletedThis completed study looked at 189 adults with type 1 diabetes who used one of three advanced hybrid closed-loop insulin pump systems: Medtronic Minimed 780G, Tandem T Slim X2, or CamAPS Fx. The goal was to see which system helped patients keep their blood sugar in a very tight r…
Sponsor: Castilla-La Mancha Health Service • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Brain scans reveal clues to uneven muscle weakness in progressive MS
Knowledge-focused CompletedThis study looked at 46 people with progressive multiple sclerosis who have more weakness on one side of their body. Researchers used MRI scans to see how damage in the brain and spinal cord relates to muscle strength in each limb. The goal was to better understand what causes ph…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New tests could help spot hidden blood disorder in seniors
Knowledge-focused CompletedThis study followed 37 adults over age 60 with unexplained low platelet counts to see if certain tests could predict immune thrombocytopenic purpura (ITP). Participants had blood tests, bone marrow biopsies, and a short course of the steroid prednisone. The goal was to find which…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Study reveals mental health ties to diabetes Self-Care in teens and young adults
Knowledge-focused CompletedThis completed study looked at 115 young people aged 10 to 25 with type 1 diabetes in Spain. Participants filled out an online survey about their mental health, eating habits, and how well they manage their diabetes. The goal was to see if these factors differ by age and sex, and…
Sponsor: University of Alicante • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Lupus Patients' quality of life under the microscope in new study
Knowledge-focused CompletedThis study followed 356 adults with lupus over time to see how the disease impacts their quality of life. Participants filled out questionnaires about their symptoms, fatigue, mood, and daily activities. The goal was to better understand what factors affect well-being in lupus, w…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Ocrelizumab's brain impact in progressive MS examined
Knowledge-focused CompletedThis study analyzed MRI scans from 732 people with primary-progressive multiple sclerosis who took part in the ORATORIO trial. Researchers wanted to see if ocrelizumab changes a part of the brain called the choroid plexus, which may be involved in inflammation. The study was obse…
Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New study tests earlier treatment for low blood sugar in type 1 diabetes
Knowledge-focused CompletedThis study looked at whether giving oral glucose at a slightly higher blood sugar threshold can prevent mild-to-moderate hypoglycemia in people with type 1 diabetes. Thirty adults with type 1 diabetes were given 16g of oral carbohydrates when their blood glucose reached a target …
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Teens with diabetes test smart insulin pumps against surprise breakfasts
Knowledge-focused CompletedThis pilot study tested two automated insulin delivery systems (Medtronic 780G and Tandem t:slim X2) in 20 adolescents with type 1 diabetes. Participants ate breakfasts without telling the device how many carbs they were eating. The goal was to see how well each system controlled…
Sponsor: University of Catania • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
DIY insulin systems under the microscope: safe for exercise?
Knowledge-focused CompletedThis study looked at how automated insulin delivery (AID) systems, including homemade DIY versions, perform in physically active adults with type 1 diabetes. Over six weeks, 76 participants wore their own AID systems and a fitness tracker while sharing glucose and insulin data. T…
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Lupus patients get custom steroid tapering plan in new study
Knowledge-focused CompletedThis study tested a personalized way to reduce steroid doses in 72 lupus patients. Doctors used blood tests and regular check-ups over 3 months to safely lower prednisone. The goal was to find the best tapering schedule for each person, minimizing side effects while controlling t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
AI boosts doctor accuracy for rare skin diseases in new study
Knowledge-focused CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors diagnose rare and tricky skin conditions like generalized pustular psoriasis (GPP). Fifteen doctors, including both general practitioners and dermatologists, looked at 100 skin images. They first ga…
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Robot arm learns to help: new Vision-Guided system aids wheelchair users
Knowledge-focused CompletedThis study tested a new way to control a robotic arm mounted on a power wheelchair. The arm uses a camera to help guide movements, making tasks like grabbing a drink easier. 21 adults who use power wheelchairs and have trouble with everyday tasks took part. They compared the new …
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New french questionnaire to measure physical activity in disabled individuals
Knowledge-focused CompletedThis study tested a French version of a questionnaire that measures physical activity levels in people with physical disabilities. Fifty participants with conditions like stroke, multiple sclerosis, or Parkinson's disease filled out the questionnaire twice, two weeks apart. The g…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New tool helps patients and doctors choose psoriasis treatments together
Knowledge-focused CompletedThis study aimed to create and test a decision aid for people with psoriasis or psoriatic arthritis who are starting or switching treatments. Researchers worked with 37 patients and their doctors to design a tool that supports shared decision-making. The goal was to help patients…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Brain fog in myasthenia gravis: new study explores thinking problems
Knowledge-focused CompletedThis completed study looked at how common cognitive (thinking) difficulties are in 150 people with myasthenia gravis. Researchers measured memory, attention, and other mental skills, and how these issues affect daily activities, work, and quality of life. The goal is to better un…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Scientists uncover clues to how MS drug calms the immune system
Knowledge-focused CompletedThis study looked at how the drug cladribine affects the immune system in people with multiple sclerosis (MS). Researchers analyzed blood samples from 77 MS patients and healthy donors to understand the drug's anti-inflammatory effects. The goal was to learn more about how cladri…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Virtual reality could sharpen MS brain testing
Knowledge-focused CompletedThis study compared traditional pencil-and-paper tests with virtual reality tasks (like driving simulations and a virtual supermarket) to assess attention and executive function in 60 people with relapsing-remitting multiple sclerosis. The goal was to see if VR can better detect …
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Scientists test designer immune molecules in autoimmune diseases
Knowledge-focused CompletedThis study looked at whether specially engineered versions of a natural immune protein (IL-2) can selectively boost regulatory T cells, which help calm the immune system. Researchers took blood samples from 67 people with various autoimmune or inflammatory conditions and tested t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Coaching eases tough move to adult rheumatology care
Knowledge-focused CompletedThis study tested whether coaching sessions are practical for young people with rheumatic diseases moving from pediatric to adult care. 26 participants received up to 8 coaching sessions covering self-advocacy, medication management, and future planning. The main goal was to see …
Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Scientists probe fat metabolism in diabetic Patients' arteries
Knowledge-focused CompletedThis study looked at how diabetes changes the way certain fats (arachidonic acid) are processed in fatty plaques that build up in the carotid artery. Researchers compared plaque samples from 204 diabetic and non-diabetic patients undergoing surgery for carotid stenosis. The goal …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Scientists probe immune cells behind rare anemia
Knowledge-focused CompletedThis study looked at how certain immune cells, called T cells, behave in people with autoimmune hemolytic anemia, a condition where the body attacks its own red blood cells. Researchers compared blood samples from 27 patients and healthy volunteers to understand the disease bette…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Blood sugar fix may unclog cholesterol in Type-1 diabetes
Knowledge-focused CompletedThis study looked at whether improving blood sugar control can restore a protein called apoC1, which helps reduce bad cholesterol. Researchers compared 160 type-1 diabetes patients with poor blood sugar control to 80 healthy controls. They took blood samples to measure how well a…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Pemphigus study digs into hidden emotional struggles
Knowledge-focused CompletedThis study looked at 48 adults with pemphigus, a rare blistering skin disease, to understand what makes them feel vulnerable during their illness. Researchers used interviews and questionnaires to explore factors like misdiagnosis, differences in how patients and doctors see dise…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Does a potent steroid cream cause fluid retention? new study investigates
Knowledge-focused CompletedThis study measured fluid retention in 30 people with bullous pemphigoid who were treated with a strong steroid cream (clobetasol propionate). Researchers used bioimpedance to track changes in body water over 30 days. The goal was to understand if the cream causes fluid buildup a…
Phase 4 • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Lockdown diaries: 1,300 patients reveal hidden health risks
Knowledge-focused CompletedThis study looked at how the COVID-19 lockdown changed the health habits and medical care of 1,343 people with chronic conditions like heart disease, multiple sclerosis, and hemophilia. Researchers used phone surveys to track medication use, lifestyle changes, and access to healt…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Blood filter showdown: which method clears harmful antibodies faster?
Knowledge-focused CompletedThis study compares two blood-filtering techniques—plasma exchange and immunoadsorption—in 40 patients with severe kidney failure caused by ANCA vasculitis or Goodpasture disease. The goal is to see which method removes disease-causing antibodies more quickly. Results may help do…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Can Role-Play help diabetics master their glucose monitor? small study says maybe.
Knowledge-focused CompletedThis study tested whether simulation (a kind of role-play) can help adults with insulin-dependent diabetes learn to use the Freestyle Libre glucose monitor. Twenty-seven patients who had already completed a standard education program took part. The goal was to see if simulation i…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Pregnancy's secret signals: could tiny molecules explain arthritis and lupus flares?
Knowledge-focused CompletedThis study looked at how small molecules called microRNAs change during pregnancy in women with rheumatoid arthritis or lupus. Researchers collected blood and urine samples before and after pregnancy from 50 women to see if these changes relate to disease activity. The goal is to…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New study tracks Real-Life workouts and glucose in type 1 diabetes
Knowledge-focused CompletedThis study followed 87 active adults with type 1 diabetes who use automated insulin pumps and exercise at least twice a week. Researchers tracked their blood sugar levels before, during, and after exercise to see how well the pumps handle physical activity. The goal was to learn …
Sponsor: ISIS Diabete Service • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:15 UTC
-
Study: when you exercise matters for blood sugar control in type 1 diabetes
Knowledge-focused CompletedThis study looked at how different types of exercise—short bursts of intense cycling versus steady moderate cycling—affect blood sugar levels in adults with type 1 diabetes. It also compared exercising after a meal versus on an empty stomach. Twenty-one physically active adults c…
Sponsor: Universite du Littoral Cote d'Opale • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Could cancer trick the body into attacking its own platelets?
Knowledge-focused CompletedThis study looked at 33 adults who had both immune thrombocytopenia (ITP) — a condition where the immune system destroys platelets — and cancer. Researchers wanted to see if treating the cancer could also improve ITP. They also investigated whether cancer cells might mimic platel…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Brain scans reveal hidden damage years after pregnancy complication
Knowledge-focused CompletedThis study uses special MRI scans to see if the white matter in the brain gets worse over time in women who have obstetric antiphospholipid syndrome, a condition that can cause pregnancy loss. Researchers will compare brain images from 40 women who were part of an earlier study. …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New test could reveal if arthritis patients are taking their meds
Knowledge-focused CompletedThis study looked at how the drug methotrexate and its main byproduct leave the body in people with rheumatoid arthritis. Researchers measured levels in urine to create a reference range. This could help doctors identify patients who are not taking their medication as prescribed.
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Lupus kidney clue found in rare antibody?
Knowledge-focused CompletedThis study looked at whether a specific antibody, called anti-GBM, could be a useful marker for lupus nephritis—a serious kidney complication of lupus. Researchers tested stored blood samples from 100 people with lupus (some with kidney issues, some without) and compared them to …
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Can lowering inflammation protect your heart? new study explores link in arthritis patients
Knowledge-focused CompletedThis study looked at how reducing inflammation might lower heart disease risk in people with rheumatoid arthritis. Researchers measured heart blood flow in 74 patients before and after treatment with certolizumab, a drug that fights inflammation. The goal was to see if better con…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
MS drug in breastmilk: new study checks baby safety
Knowledge-focused CompletedThis study looked at how much of the multiple sclerosis drug ocrelizumab gets into breastmilk and whether it affects babies' immune cells. Twenty-six breastfeeding mothers with MS or clinically isolated syndrome took part. Researchers measured drug levels in breastmilk and checke…
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Blood test may help tell apart two forms of diabetes
Knowledge-focused CompletedThis study looked at whether measuring pancreatic polypeptide levels after a meal can help doctors tell the difference between type 1 diabetes and type 3c diabetes (caused by pancreas damage). Thirty-six adults with either type 1 or type 3c diabetes gave blood and stool samples. …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New study reveals how fatigue impacts psoriasis and arthritis patients
Knowledge-focused CompletedThis study looked at fatigue in 33 adults with psoriatic arthritis or psoriasis. Researchers used questionnaires to measure tiredness and see how it relates to disease severity and treatments. The goal was to better understand fatigue and its impact on quality of life.
Sponsor: Centre Hospitalier Henri Duffaut - Avignon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Researchers dive into why scleroderma and lung hypertension weaken the heart
Knowledge-focused CompletedThis study looked at 43 adults with scleroderma or unexplained pulmonary arterial hypertension (PAH) to understand why the right side of the heart weakens. Researchers collected blood and tissue samples during routine procedures and measured heart function over 6 months. The goal…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Can a new MRI shortcut cut scan time without sacrificing quality?
Knowledge-focused CompletedThis study tested whether a technique called compressed sensing can speed up a specific type of brain MRI (QSM) without losing image quality. 82 people, including some with multiple sclerosis, had extra scan sequences added to their routine MRI. The goal was to see if the faster …
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New MRI study aims to solve MS's 'Clinical-Radiological Paradox'
Knowledge-focused CompletedThis study looked at 94 people with relapsing-remitting multiple sclerosis to better understand why standard MRI scans often don't match a person's actual walking ability. Researchers used advanced MRI to measure damage in brain and spinal cord pathways important for movement and…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New blood test benchmarks for pregnant women could prevent dangerous clots
Knowledge-focused CompletedThis study looked at 100 pregnant women to determine normal ranges for a blood test called dRVVT, which checks for clotting problems. The goal is to better identify antiphospholipid syndrome, a condition that raises the risk of blood clots and pregnancy complications. By establis…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Sleep apnea may be hidden danger for type 1 diabetes patients
Knowledge-focused CompletedThis completed study looked at 825 adults with type 1 diabetes who use an insulin pump to see how many also have obstructive sleep apnea. Researchers used overnight oxygen tests and sleep studies to find cases. The goal was to understand if sleep apnea is linked to diabetes compl…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Survey reveals why rheumatism patients struggle with Follow-Up care
Knowledge-focused CompletedThis completed study surveyed 229 people with chronic inflammatory rheumatism (like rheumatoid arthritis) and their doctors to find out what makes it hard to follow care recommendations after a hospital visit. The goal was to identify barriers to good outpatient management. No tr…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Rare disease genetics unlocked: new study maps APECED mutations
Knowledge-focused CompletedThis study looked at the genetic makeup of 29 people with APECED syndrome, a rare autoimmune disorder. Researchers aimed to find common gene mutations and link them to symptoms. The goal was to better understand the disease and improve diagnosis.
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Could a mother's virus raise her baby's heart defect risk? new study investigates.
Knowledge-focused CompletedThis study looked at whether viral infections and diabetes in pregnant women are linked to congenital heart defects in their babies. Researchers analyzed blood and stool samples from 114 women to detect viruses and immune responses. The goal was to gather knowledge for future lar…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Blood test for humira levels could personalize arthritis care
Knowledge-focused CompletedThis study looked at 69 adults with rheumatoid arthritis who were taking the drug adalimumab (Humira). Researchers measured drug levels in the blood over 6 months to see if they could predict who would respond well to treatment. The goal was to find a way to adjust doses early, i…
Phase 4 • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Fat clues in diabetic pregnancies could predict baby size
Knowledge-focused CompletedThis study looked at 186 pregnant women with type 1 or type 2 diabetes to understand how fats in the blood relate to baby birth weight. Researchers measured blood fats, diet, and placenta genes. The goal is to find new ways to prevent babies from being born too large, which can c…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Scleroderma mystery: could a simple hormone be involved?
Knowledge-focused CompletedThis study looked at whether people with systemic sclerosis (scleroderma) have higher levels of the hormone prolactin in their blood. Researchers measured prolactin in 71 patients and compared them to healthy volunteers. The goal was to understand if prolactin plays a role in the…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Scientists probe immune Cells' role in skin scarring disease
Knowledge-focused CompletedThis study looked at how B cells, a type of immune cell, may contribute to scarring in people with systemic sclerosis (scleroderma). Researchers compared skin and blood samples from 71 participants, including patients and healthy volunteers. The goal was to understand the disease…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Could white blood cells drive skin scarring in scleroderma?
Knowledge-focused CompletedThis completed study examined whether eosinophils, a type of white blood cell, contribute to fibrosis (scarring) in systemic sclerosis, an autoimmune disease. Researchers compared blood samples from 40 patients with systemic sclerosis and 30 healthy volunteers, with optional skin…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Serotonin receptor may be key to unlocking MS mysteries
Knowledge-focused CompletedThis study looked at whether a specific serotonin receptor, called 5-HT7, could be used as a biomarker for multiple sclerosis (MS). Researchers measured the receptor on different blood cells from 100 people, including those with MS and healthy volunteers. The goal was to better u…
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Scleroderma lung study reveals how pneumonia progresses over two years
Knowledge-focused CompletedThis study followed 56 adults with systemic sclerosis (scleroderma) who also had a serious lung complication called diffuse infiltrating pneumonia. Researchers measured lung function at 12 and 24 months to see how it changed and to identify factors that might predict faster decli…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Laser light may reveal hidden clues in rare skin disease
Knowledge-focused CompletedThis study tested whether a special laser technique called Raman spectroscopy can measure skin fibrosis (hardening) in people with systemic sclerosis, a rare autoimmune disease. Twenty-six adults with the condition had their skin scanned with the laser. The goal was to see if thi…
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Lupus care under the microscope: new study reveals hidden challenges
Knowledge-focused CompletedThis completed study looked at data from 1,000 lupus patients and gathered expert opinions to find where diagnosis and treatment fall short. Researchers reviewed existing information, discussed with doctors, and built consensus on unmet needs. The goal is to publish findings that…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Study reveals hidden breathing issues in severe MS patients
Knowledge-focused CompletedThis study looked at breathing problems in 70 people with severe multiple sclerosis (MS). Participants had sleep and lung tests to check for breathing muscle weakness. The goal was to better understand how MS affects breathing, not to test a new treatment.
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
38,000 arthritis patients tracked: is abatacept safe Long-Term?
Knowledge-focused CompletedThis completed study looked at the safety of the arthritis drug abatacept in over 38,000 people with rheumatoid or psoriatic arthritis in Denmark. Researchers used a national health registry to track rates of cancers and other side effects. The goal was to better understand the d…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Diabetes and mental health: a Two-Year study to personalize care
Knowledge-focused CompletedThis completed study followed 1,290 adults with type 1 or type 2 diabetes for two years. Researchers tracked mental health issues like depression, anxiety, and eating problems alongside daily blood sugar levels using smartphone surveys and continuous glucose monitors. The goal wa…
Sponsor: Forschungsinstitut der Diabetes Akademie Mergentheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Could pregnancy loss signal future cancer risk? new study investigates
Knowledge-focused CompletedThis study followed over 1,500 women who had pregnancy losses and were tested for antiphospholipid syndrome (APS) and other clotting disorders. Researchers compared cancer rates among women with APS, those with other clotting gene changes, and those with no clotting issues. The g…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Spinal fluid clues may predict MS years before symptoms
Knowledge-focused CompletedThis study examined 100 people who had brain MRI findings suggesting possible multiple sclerosis (MS) but no symptoms yet. Researchers measured four new biomarkers in their spinal fluid and blood to see if these could predict who would later develop MS. The goal was to improve ea…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC